Devanga Ragupathi NK, Veeraraghavan B. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update. Ann Clin Microbiol Antimicrob. 2019 Feb 4;18(1):7. doi: 10.1186/s12941-019-0306-0. PMID: 30717798; PMCID: PMC6360774.

Amladi AU, Abirami B, Devi SM, Sudarsanam TD, Kandasamy S, Kekre N, Veeraraghavan B, Sahni RD. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections. Indian J Med Res. 2019 Feb;149(2):185-191. doi: 10.4103/ijmr.IJMR_2086_17. PMID: 31219082; PMCID: PMC6563748.

Bakthavatchalam YD, Ralph R, Veeraraghavan B, Babu P, Munusamy E. Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus? Infect Dis Ther. 2019 Mar;8(1):51-62. doi: 10.1007/s40121-018-0224-z. Epub 2018 Nov 21. PMID: 30460607; PMCID: PMC6374240.

Khiangte HL, Robinson Vimala L, Veeraraghavan B, Yesudhason BL, Karuppusami R. Can the imaging manifestations of melioidosis prognosticate the clinical outcome? A 6-year retrospective study. Insights Imaging. 2019 Feb 13;10(1):17. doi: 10.1186/s13244-019-0708-8. PMID: 30758675; PMCID: PMC6375099.

Agrawal V, Valson AT, Mohapatra A, David VG, Alexander S, Jacob S, Bakthavatchalam YD, Prakash JAJ, Balaji V, Varughese S. Fast and furious: a retrospective study of catheter-associated bloodstream infections with internal jugular nontunneled hemodialysis catheters at a tropical center. Clin Kidney J. 2019 Feb 5;12(5):737-744. doi: 10.1093/ckj/sfy138. PMID: 31583098; PMCID: PMC6768464.

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Gajendran R, Anandan S, Walia K, Veeraraghavan B. Horizontal Transfer of Antimicrobial Resistance Determinants Among Enteric Pathogens Through Bacterial Conjugation. Curr Microbiol. 2019 Jun;76(6):666-672. doi: 10.1007/s00284-019-01676-x. Epub 2019 Apr 2. PMID: 30941540.

Devanga Ragupathi NK, Veeraraghavan B. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update. Ann Clin Microbiol Antimicrob. 2019 Feb 4;18(1):7. doi: 10.1186/s12941-019-0306-0. PMID: 30717798; PMCID: PMC6360774.

Amladi AU, Abirami B, Devi SM, Sudarsanam TD, Kandasamy S, Kekre N, Veeraraghavan B, Sahni RD. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections. Indian J Med Res. 2019 Feb;149(2):185-191. doi: 10.4103/ijmr.IJMR_2086_17. PMID: 31219082; PMCID: PMC6563748.

Bakthavatchalam YD, Ralph R, Veeraraghavan B, Babu P, Munusamy E. Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus? Infect Dis Ther. 2019 Mar;8(1):51-62. doi: 10.1007/s40121-018-0224-z. Epub 2018 Nov 21. PMID: 30460607; PMCID: PMC6374240.

Khiangte HL, Robinson Vimala L, Veeraraghavan B, Yesudhason BL, Karuppusami R. Can the imaging manifestations of melioidosis prognosticate the clinical outcome? A 6-year retrospective study. Insights Imaging. 2019 Feb 13;10(1):17. doi: 10.1186/s13244-019-0708-8. PMID: 30758675; PMCID: PMC6375099.

Agrawal V, Valson AT, Mohapatra A, David VG, Alexander S, Jacob S, Bakthavatchalam YD, Prakash JAJ, Balaji V, Varughese S. Fast and furious: a retrospective study of catheter-associated bloodstream infections with internal jugular nontunneled hemodialysis catheters at a tropical center. Clin Kidney J. 2019 Feb 5;12(5):737-744. doi: 10.1093/ckj/sfy138. PMID: 31583098; PMCID: PMC6768464.

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Gajendran R, Anandan S, Walia K, Veeraraghavan B. Horizontal Transfer of Antimicrobial Resistance Determinants Among Enteric Pathogens Through Bacterial Conjugation. Curr Microbiol. 2019 Jun;76(6):666-672. doi: 10.1007/s00284-019-01676-x. Epub 2019 Apr 2. PMID: 30941540.

Muthuirulandi Sethuvel DP, Veeraraghavan B, Vasudevan K, Devanga Ragupathi NK, Murugan D, Walia K, Anandan S. Complete genome analysis of clinical Shigella strains reveals plasmid pSS1653 with resistance determinants: a triumph of hybrid approach. Gut Pathog. 2019 Nov 6;11:55. doi: 10.1186/s13099-019-0334-5. PMID: 31709015; PMCID: PMC6836418.

Vijayakumar S, S BA, Kanthan K, Veeraraghavan B. Whole-genome shotgun sequences of seven colistin-resistant Acinetobacter baumannii isolates from bacteraemia. J Glob Antimicrob Resist. 2018 Mar;12:155-156. doi: 10.1016/j.jgar.2018.01.012. Epub 2018 Feb 22. PMID: 29410025.

Dharmapalan D, Inbanathan FY, Kharche S, Patil A, Joshi S, Yewale V, Daniel JLK, Walia K, Veeraraghavan B. Whole genome shotgun sequences of Streptococcus pyogenes causing acute pharyngitis from India. Data Brief. 2018 Apr 1;18:1340-1349. doi: 10.1016/j.dib.2018.03.129. PMID: 29900313; PMCID: PMC5996613.

Veeraraghavan B, Jesudason MR, Prakasah JAJ, Anandan S, Sahni RD, Pragasam AK, Bakthavatchalam YD, Selvakumar RJ, Dhole TN, Rodrigues C, Roy I, Joshi S, Chaudhuri BN, Chitnis DS. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report. Indian J Med Microbiol. 2018 Jan-Mar;36(1):32-36. doi: 10.4103/ijmm.IJMM_17_415. PMID: 29735823.

Pragsam AK, Kumar DT, Doss CGP, Iyadurai R, Satyendra S, Rodrigues C, Joshi S, Roy I, Chaudhuri BN, Chitnis DS, Tapan D, Veeraraghavan B. In silico and In vitro activity of ceftolozane/tazobactam against pseudomonas aeruginosa collected across Indian hospitals. Indian J Med Microbiol. 2018 Jan-Mar;36(1):127-130. doi: 10.4103/ijmm.IJMM_17_349. PMID: 29735843.

Jayaraman Y, Veeraraghavan B, Chethrapilly Purushothaman GK, Sukumar B, Kangusamy B, Nair Kapoor A, Gupta N, Mehendale SM; Hospital Based Sentinel Surveillance of Bacterial Meningitis (HBSSBM) Network Team. Burden of bacterial meningitis in India: Preliminary data from a hospital based sentinel surveillance network. PLoS One. 2018 May 16;13(5):e0197198. doi: 10.1371/journal.pone.0197198. PMID: 29768458; PMCID: PMC5955554.

Abi M, Chaitra S, Nabarro L, George MV, Balaji V. Hypervirulent, Regulator of Mucoid Phenotype A Positive Klebsiella pneumoniae Liver Abscess. J Glob Infect Dis. 2018 Jan-Mar;10(1):30-31. doi: 10.4103/jgid.jgid_86_16. PMID: 29563724; PMCID: PMC5850764.

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Inbanathan FY, Veeraraghavan B. Accurate differentiation of Escherichia coli and Shigella serogroups: challenges and strategies. New Microbes New Infect. 2017 Sep 23;21:58-62. doi: 10.1016/j.nmni.2017.09.003. PMID: 29204286; PMCID: PMC5711669.

Sengupta M, Prabhakar AK, Satyendra S, Thambu D, Abraham OC, Balaji V, Chen HW, Chao CC, Ching WM, Prakash JA. Utility of Loop-mediated Isothermal Amplification Assay, Polymerase Chain Reaction, and ELISA for Diagnosis of Leptospirosis in South Indian Patients. J Glob Infect Dis. 2017 Jan-Mar;9(1):3-7. doi: 10.4103/0974-777X.192967. PMID: 28250618; PMCID: PMC5330041.

Jayaraman Y, Mehendale S, Jayaraman R, Varghese R, Chethrapilly Purushothaman GK, Rajkumar P, Sukumar B, Pillai RK, Mohan G, Radhakrishnan DN, Sridharan S, Babu N, Ganesapillai M, Rao SP, Kar SK, Manchanda V, Kanga A, Verghese VP, Veeraraghavan B. Immunochromatography in CSF improves data on surveillance of S. pneumoniae meningitis in India. J Infect Public Health. 2018 Sep-Oct;11(5):735-738. doi: 10.1016/j.jiph.2018.01.002. Epub 2018 Mar 30. PMID: 29606535.

Vikram Mathews, Alok Srivastava, Biju George, Anu Korula, Susmitha Perumalla, Fouzia Nambiathayil Abubacker, Nisham P N, Anup Devasia, Aby Abraham, Veeraraghavan Balaji and Kavitha M Lakshmi. Multi-Drug Resistant Organisms Are Common in Fecal Surveillance Cultures and Do Not Predict Bacteremia but Correlate with Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplants. Blood 2016 128:3406. Link

Shalini Anandan, Lydia Jennifer, Agila Kumari Pragasam, Baby Abirami Shankar, Balaji Veeraraghavan, John Victor Peter and Shoma V Rao. Synergy Testing between Sulbactam and Meropenem/ Colistin in MDR Acinetobacter baumannii-calcoaceticus Complex Isolated from Ventilator Associated Pneumonia. Journal of Infectious Disease and Therapy.2016; 4:299. doi:10.4172/2332-0877.1000299

Anandan S, Muthuirulandi Sethuvel DP, Gajendiren R, Verghese VP, Walia K, Veeraraghavan B. Molecular characterization of antimicrobial resistance in clinical Shigella isolates during 2014 and 2015: trends in South India. Germs. 2017 Sep 1;7(3):115-122. doi: 10.18683/germs.2017.1116. PMID: 28932711; PMCID: PMC5601094.

Verghese VP, Veeraraghavan B, Jayaraman R, Varghese R, Neeravi A, Jayaraman Y, Thomas K, Mehendale SM. incidence of penicillin- and cefotaxime-resistant Streptococcus pneumoniae causing meningitis in India: Time for revision of treatment guidelines? Indian J Med Microbiol. 2017 Apr-Jun;35(2):228-236. doi: 10.4103/ijmm.IJMM_17_124. PMID: 28681811.

Muthuirulandi Sethuvel DP, Devanga Ragupathi NK, Anandan S, Verghese VP, Veeraraghavan B. First report on whole-genome shotgun sequences of 23 biochemically indistinguishable clinical Shigella isolates. J Glob Antimicrob Resist. 2017 Jun;9:32-33. doi: 10.1016/j.jgar.2016.12.009. Epub 2017 Feb 17. PMID: 28219825.

Rajkumar S, Sistla S, Manoharan M, Sugumar M, Nagasundaram N, Parija SC, Ray P, Bakthavatchalam YD, Veeraraghavan B, Kapil A, Walia K, Ohri VC. Prevalence and genetic mechanisms of antimicrobial resistance in Staphylococcus species: A multicentre report of the indian council of medical research antimicrobial resistance surveillance network. Indian J Med Microbiol. 2017 Jan-Mar;35(1):53-60. doi: 10.4103/ijmm.IJMM_16_427. PMID: 28303819.

Chang YT, Coombs G, Ling T, Balaji V, Rodrigues C, Mikamo H, Kim MJ, Rajasekaram DG, Mendoza M, Tan TY, Kiratisin P, Ni Y, Barry W, Xu Y, Chen YH, Hsueh PR. Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013. Int J Antimicrob Agents. 2017 Jun;49(6):734-739. doi: 10.1016/j.ijantimicag.2017.01.030. Epub 2017 Apr 20. PMID: 28435019.

Nabarro LEB, Shankar C, Pragasam AK, Mathew G, Jeyaseelan V, Veeraraghavan B, Verghese VP. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India. Pediatr Infect Dis J. 2017 Jun;36(6):e161-e166. doi: 10.1097/INF.0000000000001499. PMID: 28005691.

Dahiya S, Sharma P, Kumari B, Pandey S, Malik R, Manral N, Veeraraghavan B, Pragasam AK, Ray P, Gautam V, Sistla S, Parija SC, Walia K, Ohri V, Das BK, Sood S, Kapil A. Characterisation of antimicrobial resistance in Salmonellae during 2014-2015 from four centres across India: An ICMR antimicrobial resistance surveillance network report. Indian J Med Microbiol. 2017 Jan-Mar;35(1):61-68. doi: 10.4103/ijmm.IJMM_16_382. PMID: 28303820.

Thirumal Kumar D, Lavanya P, George Priya Doss C, Tayubi IA, Naveen Kumar DR, Francis Yesurajan I, Siva R, Balaji V. A Molecular Docking and Dynamics Approach to Screen Potent Inhibitors Against Fosfomycin Resistant Enzyme in Clinical Klebsiella pneumoniae. J Cell Biochem. 2017 Nov;118(11):4088-4094. doi: 10.1002/jcb.26064. Epub 2017 May 25. PMID: 28409871.

Shankar C, Nabarro LEB, Muthuirulandi Sethuvel DP, Raj A, Devanga Ragupathi NK, Doss GP, Veeraraghavan B. Draft genome of a hypervirulent Klebsiella quasipneumoniae subsp. similipneumoniae with novel sequence type ST2320 isolated from a chronic liver disease patient. J Glob Antimicrob Resist. 2017 Jun;9:30-31. doi: 10.1016/j.jgar.2017.01.004. Epub 2017 Mar 18. PMID: 28323229.

Pragasam AK, Veeraraghavan B, Bakthavatchalam YD, Gopi R, Aslam RF. Strengths and limitations of various screening methods for carbapenem-resistant Enterobacteriaceae including new method recommended by clinical and laboratory standards institute, 2017: A tertiary care experience. Indian J Med Microbiol. 2017 Jan-Mar;35(1):116-119. doi: 10.4103/ijmm.IJMM_17_10. PMID: 28303831.

Mathur P, Veeraraghavan B, Devanga Ragupathi NK, Inbanathan FY, Khurana S, Bhardwaj N, Kumar S, Sagar S, Gupta A. First Report on a Cluster of Colistin-Resistant Klebsiella pneumoniae Strains Isolated from a Tertiary Care Center in India: Whole-Genome Shotgun Sequencing. Genome Announc. 2017 Feb 2;5(5):e01466-16. doi: 10.1128/genomeA.01466-16. PMID: 28153885; PMCID: PMC5289671.

Goel R, Kabeerdoss J, Ram B, Prakash JA, Babji S, Nair A, Jeyaseelan L, Jeyaseelan V, Mathew J, Balaji V, Joseph G, Danda D. Serum Cytokine Profile in Asian Indian Patients with Takayasu Arteritis and its Association with Disease Activity. Open Rheumatol J. 2017 Feb 28;11:23-29. doi: 10.2174/1874312901711010023. PMID: 28400869; PMCID: PMC5366385.

Veeraraghavan B, Anandan S, Rajamani Sekar SK, Gopi R, Devanga Ragupathi NK, Ramesh S, Verghese VP, Korulla S, Mathai S, Sangal L, Joshi S. First Report on the Draft Genome Sequences of Corynebacterium diphtheriae Isolates from India. Genome Announc. 2016 Nov 23;4(6):e01316-16. doi: 10.1128/genomeA.01316-16. PMID: 27881543; PMCID: PMC5122685.

Veeraraghavan B, Neeravi AR, Devanga Ragupathi NK, Inbanathan FY, Pragasam AK, Verghese VP. Whole-Genome Shotgun Sequencing of the First Observation of Neisseria meningitidis Sequence Type 6928 in India. Genome Announc. 2016 Nov 3;4(6):e01232-16. doi: 10.1128/genomeA.01232-16. PMID: 27811110; PMCID: PMC5095480.

Veeraraghavan B, Jayaraman R, John J, Varghese R, Neeravi A, Verghese VP, Thomas K. Customized sequential multiplex PCR for accurate and early determination of invasive pneumococcal serotypes found in India. J Microbiol Methods. 2016 Nov;130:133-135. doi: 10.1016/j.mimet.2016.09.007. Epub 2016 Sep 10. PMID: 27623479.

Rose W, Veeraraghavan B, Pragasam AK, Verghese VP. Antimicrobial susceptibility profile of isolates from pediatric blood stream infections. Indian Pediatr. 2014 Sep;51(9):752-3. PMID: 25228617.

Subashini B, Adhikari DD, Verghese VP, Jeyaseelan V, Veeraraghavan B, Prakash JA. CNS Infections in Children: Experience from a Tertiary Care Center. J Glob Infect Dis. 2017 Jan-Mar;9(1):35-36. doi: 10.4103/0974-777X.194375. PMID: 28250626; PMCID: PMC5330045.

Dhiviya Prabaa MS, Naveen Kumar DR, Yesurajan IF, Anandan S, Kamini W, Balaji V. Identification of nonserotypeable Shigella spp. using genome sequencing: a step forward. Future Sci OA. 2017 Jul 7;3(4):FSO229. doi: 10.4155/fsoa-2017-0063. PMID: 29134117; PMCID: PMC5674244.

Rajamani Sekar SK, Veeraraghavan B, Anandan S, Devanga Ragupathi NK, Sangal L, Joshi S. Strengthening the laboratory diagnosis of pathogenic Corynebacterium species in the Vaccine era. Lett Appl Microbiol. 2017 Nov;65(5):354-365. doi: 10.1111/lam.12781. Epub 2017 Sep 4. PMID: 28741682.

Bakthavatchalam YD, Veeraraghavan B. Challenges, Issues and Warnings from CLSI and EUCAST Working Group on Polymyxin Susceptibility Testing. J Clin Diagn Res. 2017 Aug;11(8):DL03-DL04. doi: 10.7860/JCDR/2017/27182.10375. Epub 2017 Aug 1. PMID: 28969129; PMCID: PMC5620769.

Balaji V, Yamuna DB, Francis YI, Priya Doss G. Molecular characterization of Panton-Valentine leukocidin (PVL) toxin-encoding phages from South India. New Microbes New Infect. 2017 Aug 25;20:34-38. doi: 10.1016/j.nmni.2017.08.005. PMID: 29158906; PMCID: PMC5682882.

Deodhar D, Varghese G, Balaji V, John J, Rebekah G, Janardhanan J, Jeyaraman R, Jasmine S, Mathews P. Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact. J Glob Infect Dis. 2015 Jul-Sep;7(3):97-102. doi: 10.4103/0974-777X.162234. PMID: 26392716; PMCID: PMC4557147.

Tunny Sebastiana, Shalini Anandanb, Visalakshi Jeyaseelana, Lakshmanan Jeyaseelana, Kavitha Ramanathana, Balaji Veeraraghavan. Role of seasonality and rainfall in Vibrio cholerae infections: A time series model for 11 years surveillance data. Clinical Epidemiology and Global Health. 2015; 3(3): 144-148

Chandy SJ, Naik GS, Balaji V, Jeyaseelan V, Thomas K, Lundborg CS. High cost burden and health consequences of antibiotic resistance: the price to pay. J Infect Dev Ctries. 2014 Sep 12;8(9):1096-102. doi: 10.3855/jidc.4745. PMID: 25212073.

Lai CC, Lee K, Xiao Y, Ahmad N, Veeraraghavan B, Thamlikitkul V, Tambyah PA, Nelwan RH, Shibl AM, Wu JJ, Seto WH, Hsueh PR. High burden of antimicrobial drug resistance in Asia. J Glob Antimicrob Resist. 2014 Sep;2(3):141-147. doi: 10.1016/j.jgar.2014.02.007. Epub 2014 Mar 28. PMID: 27873720.

Indian Network for Surveillance of Antimicrobial Resistance (INSAR) group, India. Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern. Indian J Med Res. 2013 Feb;137(2):363-9. PMID: 23563381; PMCID: PMC3657861.

Govind B, Veeraraghavan B, Anandan S, Thomas N. Haemophilus parainfluenzae: report of an unusual cause of neonatal sepsis and a literature review. J Infect Dev Ctries. 2012 Oct 19;6(10):748-50. doi: 10.3855/jidc.2243. PMID: 23103898.

Moses V, Jerobin J, Nair A, Sathyendara S, Balaji V, George IA, Peter JV. Enterococcal Bacteremia is Associated with Prolonged Stay in the Medical Intensive Care Unit. J Glob Infect Dis. 2012 Jan;4(1):26-30. doi: 10.4103/0974-777X.93758. PMID: 22529624; PMCID: PMC3326954.

Varughese S, Mohapatra A, Sahni R, Balaji V, Tamilarasi V. Renal allograft recipient with melioidosis of the urinary tract. Transpl Infect Dis. 2011 Feb;13(1):95-6. doi: 10.1111/j.1399-3062.2010.00553.x. PMID: 21299774.

Chaudhuri BN, Rodrigues C, Balaji V, Iyer R, Sekar U, Wattal C, Chitnis DS, Dhole TN, Joshi S. Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). J Assoc Physicians India. 2011 May;59:287-92. PMID: 21751604.

Chacko B, Peter JV, Balaji V. The new delhi metallo-Beta-lactamases: their origins and implication for the intensivist. J Glob Infect Dis. 2011 Jul;3(3):309. doi: 10.4103/0974-777X.83540. PMID: 21887070; PMCID: PMC3162824.

Poongothai S, Balaji Veeraraghavan, Reddy R, Ilavarasan R. Validated and stability indicating dissolution test with reverse PHASE-HPLC analysis for rasagiline mesylate in tablet dosage form. International Journal of Pharmaceutical Sciences Review and Research. 2011;10(2):18-23

Veeraraghavan B. Newer β-lactam and β-lactamase inhibitor combinations available in India: consensus and controversies. Indian J Med Microbiol. 2011 Jul-Sep;29(3):315-6. doi: 10.4103/0255-0857.83924. PMID: 21860121.

James P, Gupta R, Christopher DJ, Thankagunam B, Veeraraghavan B. MDR- and XDR-TB among suspected drug-resistant TB patients in a tertiary care hospital in India. Clin Respir J. 2011 Jan;5(1):19-25. doi: 10.1111/j.1752-699X.2009.00184.x. PMID: 21159137.

Balaji V, Daley P, Anand AA, Sudarsanam T, Michael JS, Sahni RD, Chordia P, George IA, Thomas K, Ganesh A, John KR, Mathai D. Risk factors for MDR and XDR-TB in a tertiary referral hospital in India. PLoS One. 2010 Mar 4;5(3):e9527. doi: 10.1371/journal.pone.0009527. PMID: 20209106; PMCID: PMC2832005.

Abhilash KP, Veeraraghavan B, Abraham OC. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India. J Assoc Physicians India. 2010 Dec;58 Suppl:13-7. PMID: 21563608.

Korah S, Braganza A, Jacob P, Balaji V. An "epidemic" of post cataract surgery endophthalmitis by a new organism. Indian J Ophthalmol. 2007 Nov-Dec;55(6):464-6. doi: 10.4103/0301-4738.36486. PMID: 17951908; PMCID: PMC2635971.

Balaji V, Jesudason MV, Sridharan G, Subramanian K. Detection of virulence attributes of Burkholderia pseudomallei. Indian J Med Res. 2004 Mar;119(3):101-6. PMID: 15115160.

Jesudason MV, Balaji V, Mukundan U, Thomson CJ. Ecological study of Vibrio cholerae in Vellore. Epidemiol Infect. 2000 Apr;124(2):201-6. doi: 10.1017/s095026889900357x. PMID: 10813143; PMCID: PMC2810901.

Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, Anandan S, Ramasubramanian V, Swaminathan S, Gopalakrishnan R, Soman R, Abraham OC, Ohri VC, Walia K. Newer β-Lactam/β-Lactamase inhibitor for multidrug-resistant gram-negative infections: Challenges, implications and surveillance strategy for India. Indian J Med Microbiol. 2018 Jul-Sep;36(3):334-343. doi: 10.4103/ijmm.IJMM_18_326. PMID: 30429384.

Veeraraghavan B, Pragasam AK, Manesh A, Rupali P, Iyadurai R, Rodrigues C, Joshi S, Roy I, Chaudhuri BN, Chitnis DS, Tapan D. Dosing strategy based on prevailing aminoglycoside minimum inhibitory concentration in India: Evidence and issues. Indian J Med Microbiol. 2017 Oct-Dec;35(4):585-587. doi: 10.4103/ijmm.IJMM_17_386. PMID: 29405154.

Veeraraghavan B, Lal B, Devanga Ragupathi NK, Neeravi IR, Jeyaraman R, Varghese R, Paul MM, Baskaran A, Ranjan R. First genome report on novel sequence types of Neisseria meningitidis: ST12777 and ST12778. J Glob Antimicrob Resist. 2018 Mar;12:117-118. doi: 10.1016/j.jgar.2017.11.014. Epub 2017 Dec 18. PMID: 29269053.

Anandan S, Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Thangamani S, Veeraraghavan B. Prevailing clone (ST69) of Vibrio cholerae O139 in India over 10 years. Gut Pathog. 2017 Nov 6;9:60. doi: 10.1186/s13099-017-0210-0. PMID: 29142593; PMCID: PMC5674738.

Veeraraghavan B, Devanga Ragupathi NK, Santhanam S, Verghese VP, Inbanathan FY, Livingston C. Whole genome shotgun sequencing of Indian strains of Streptococcus agalactiae. Genom Data. 2017 Oct 2;14:63-65. doi: 10.1016/j.gdata.2017.10.001. PMID: 29021957; PMCID: PMC5633162.

Sangal L, Joshi S, Anandan S, Balaji V, Johnson J, Satapathy A, Haldar P, Rayru R, Ramamurthy S, Raghavan A, Bhatnagar P. Resurgence of Diphtheria in North Kerala, India, 2016: Laboratory Supported Case-Based Surveillance Outcomes. Front Public Health. 2017 Aug 30;5:218. doi: 10.3389/fpubh.2017.00218. PMID: 28913330; PMCID: PMC5582196.

Gouse M, Jayasankar V, Patole S, Veeraraghavan B, Nithyananth M. Clinical Outcomes in Musculoskeletal Involvement of Burkholderia Pseudomallei Infection. Clin Orthop Surg. 2017 Sep;9(3):386-391. doi: 10.4055/cios.2017.9.3.386. Epub 2017 Aug 4. PMID: 28861207; PMCID: PMC5567035.

Cruz MS, AlarconFalconi TM, Hartwick MA, Venkat A, Ehrlich HY, Anandan S, Ward HD, Veeraraghavan B, Naumova EN. From hospitalization records to surveillance: The use of local patient profiles to characterize cholera in Vellore, India. PLoS One. 2017 Aug 18;12(8):e0182642. doi: 10.1371/journal.pone.0182642. PMID: 28820902; PMCID: PMC5562306.

Varghese R, Jayaraman R, Veeraraghavan B. Current challenges in the accurate identification of Streptococcus pneumoniae and its serogroups/serotypes in the vaccine era. J Microbiol Methods. 2017 Oct;141:48-54. doi: 10.1016/j.mimet.2017.07.015. Epub 2017 Aug 2. PMID: 28780272.

Bakthavatchalam YD, Sudarsanam TD, Babu P, Munuswamy E, Muthuirulandi Sethuvel DP, Devanga Ragupathi NK, Veeraraghavan B. Methicillin-Susceptible Teicoplanin-Resistant Staphylococcus haemolyticus Isolate from a Bloodstream Infection with Novel Mutations in the tcaRAB Teicoplanin Resistance Operon. Jpn J Infect Dis. 2017 Jul 24;70(4):458-460. doi: 10.7883/yoken.JJID.2016.482. Epub 2017 Feb 28. PMID: 28250264.

Bakthavatchalam YD, Veeraraghavan B, Devanga Ragupathi NK, Babu P, Munuswamy E, David T. Draft genome sequence of reduced teicoplanin-susceptible and vancomycin-heteroresistant methicillin-resistant Staphylococcus aureus from sepsis cases. J Glob Antimicrob Resist. 2017 Mar;8:169-171. doi: 10.1016/j.jgar.2016.12.008. Epub 2017 Feb 23. PMID: 28216019.

Verghese VP, Veeraraghavan B, Jayaraman R, Varghese R, Neeravi A, Jayaraman Y, Thomas K, Mehendale SM. Increasing incidence of penicillin- and cefotaxime-resistant Streptococcus pneumoniae causing meningitis in India: Time for revision of treatment guidelines? Indian J Med Microbiol. 2017 Apr-Jun;35(2):228-236. doi: 10.4103/ijmm.IJMM_17_124. PMID: 28681811.

Veeraraghavan B, Shankar C, Karunasree S, Kumari S, Ravi R, Ralph R. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience. Pathog Glob Health. 2017 Jul;111(5):240-246. doi: 10.1080/20477724.2017.1340128. Epub 2017 Jul 2. PMID: 28670975; PMCID: PMC5560201.

Kasimova AA, Shneider MM, Arbatsky NP, Popova AV, Shashkov AS, Miroshnikov KA, Balaji V, Biswas I, Knirel YA. Structure and Gene Cluster of the K93 Capsular Polysaccharide of Acinetobacter baumannii B11911 Containing 5-N-Acetyl-7-N-[(R)-3-hydroxybutanoyl]pseudaminic Acid. Biochemistry (Mosc). 2017 Apr;82(4):483-489. doi: 10.1134/S0006297917040101. PMID: 28371606.

Koshy M, Jagannati M, Ralph R, Victor P, David T, Sathyendra S, Veeraraghavan B, Varghese GM. Clinical Manifestations, Antimicrobial Drug Susceptibility Patterns, and Outcomes in Melioidosis Cases, India. Emerg Infect Dis. 2019 Feb;25(2):316-320. doi: 10.3201/eid2502.170745. PMID: 30666953; PMCID: PMC6346473.

Ninan MM, George TK, Balaji V, Ramya I. Extended spectrum β-lactamase producing Shigella flexneri serotype-2 causing bacteremia in a patient with uncontrolled diabetes mellitus. Indian J Pathol Microbiol. 2016 Jul-Sep;59(3):420-1. doi: 10.4103/0377-4929.188120. PMID: 27510696.

Son S, Thamlikitkul V, Chokephaibulkit K, Perera J, Jayatilleke K, Hsueh PR, Lu CY, Balaji V, Moriuchi H, Nakashima Y, Lu M, Yang Y, Yao K, Kim SH, Song JH, Kim S, Kim MJ, Heininger U, Chiu CH, Kim YJ. Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents. Clin Microbiol Infect. 2019 Feb;25(2):250.e1-250.e7. doi: 10.1016/j.cmi.2018.04.013. Epub 2018 Apr 22. PMID: 29689428.

Joel A, Abhilash KP, Anandan S, Veeraraghavan B, Rupali P. Listeria Meningitis with Disseminated Tuberculosis in a HIV Positive Individual. J Glob Infect Dis. 2013 Jan;5(1):34-5. doi: 10.4103/0974-777X.107175. PMID: 23599618; PMCID: PMC3628234.

George N, Fredrick F, Mohapatra A, Veeraraghavan B, Kakde ST, Valson AT, Basu G. Non-O1, non-O139 Vibrio cholerae sepsis in a patient with nephrotic syndrome. Indian J Nephrol. 2013 Sep;23(5):378-80. doi: 10.4103/0971-4065.116329. PMID: 24049279; PMCID: PMC3764717.

Ramachandran P, Fitzwater SP, Aneja S, Verghese VP, Kumar V, Nedunchelian K, Wadhwa N, Veeraraghavan B, Kumar R, Meeran M, Kapil A, Jasmine S, Kumar A, Suresh S, Bhatnagar S, Thomas K, Awasthi S, Santosham M, Chandran A. Prospective multi-centre sentinel surveillance for Haemophilus influenzae type b & other bacterial meningitis in Indian children. Indian J Med Res. 2013 Apr;137(4):712-20. PMID: 23703338; PMCID: PMC3724251.

Karthik R, Pancharatnam P, Balaji V. Fatal Chromobacterium violaceum septicemia in a South Indian adult. J Infect Dev Ctries. 2012 Oct 19;6(10):751-5. doi: 10.3855/jidc.1866. PMID: 23103899.

Anandan S, Thomas N, Veeraraghavan B, Jana AK. Prevalence of extended- spectrum beta-lactamase producing Escherichia coli and Klebsiella spp in a neonatal intensive care unit. Indian Pediatr. 2009 Dec;46(12):1106-7. PMID: 20061592.

Verghese VP, Friberg IK, Cherian T, Raghupathy P, Balaji V, Lalitha MK, Thomas K, John TJ, Steinhoff MC. Community effect of Haemophilus influenzae type b vaccination in India. Pediatr Infect Dis J. 2009 Aug;28(8):738-40. doi: 10.1097/INF.0b013e318199f2a1. PMID: 19633518.

Balamurugan R, Balaji V, Ramakrishna BS. Estimation of faecal carriage of Clostridium difficile in patients with ulcerative colitis using real time polymerase chain reaction. Indian J Med Res. 2008 May;127(5):472-7. PMID: 18653911.

Viswaroop BS, Balaji V, Mathai E, Kekre NS. Melioidosis presenting as genitourinary infection in two men with diabetes. J Postgrad Med. 2007 Apr-Jun;53(2):108-10. doi: 10.4103/0022-3859.32210. PMID: 17495376.

Jesudason MV, Kandathil AJ, Balaji V. Comparison of two methods to detect carbapenemase & metallo-beta- lactamase production in clinical isolates. Indian J Med Res. 2005 Jun;121(6):780-3. PMID: 16037624.

Jesudason MV, Balaji V, Thomson CJ. Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore. Indian J Med Res. 2002 Sep;116:96-8. PMID: 12619447.

Samuel S, Mathew BS, Veeraraghavan B, Fleming DH, Chittaranjan SB, Prakash JA. In vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement. J Orthop Traumatol. 2012 Sep;13(3):131-6. doi: 10.1007/s10195-012-0191-1. Epub 2012 Mar 30. PMID: 22461001; PMCID: PMC3427696.

Angel MR, Balaji V, Prakash J, Brahmadathan KN, Mathews MS. Prevalence of inducible clindamycin resistance in gram positive organisms in a tertiary care centre. Indian J Med Microbiol. 2008 Jul-Sep;26(3):262-4. doi: 10.4103/0255-0857.42041. PMID: 18695329.

Shankar C, Karunasree S, Manesh A, Veeraraghavan B. First Report of Whole-Genome Sequence of Colistin-Resistant Klebsiella quasipneumoniae subsp. similipneumoniae Producing KPC-9 in India. Microb Drug Resist. 2019 May;25(4):489-493. doi: 10.1089/mdr.2018.0116. Epub 2018 Nov 14. PMID: 30427763.

Balaji V.. Molecular Characterisation of Stenotrophomonasmaltophilia in Nosocomial Infections: Challenges and Way Forward Journal of Clinical and Diagnostic Research 2019 13(1):DC01-DC04. DOI: 10.7860/JCDR/2019/39753.12434

Abhilash KPP, Patole S, Jambugulam M, Sathyendra S, Mitra S, Rebekah G, Yadav B, Veeraraghavan B, Abraham OC. Changing trends of Infective endocarditis in India: A South Indian experience. Journal of Cardiovascular Disease Research. 2017;8(2)56-60.

S. Manvizhi, B.S. Mathew, Anil K. Kuruvilla, Kalpana Margaret Ernest, Saravana Kumar, V Balaji, Vigil James, Denise Fleming. Adequacy of the current recommended dosage of ciprofloxacin in preterm and term neonates with sepsis. Journal of Drug Delivery and Therapeutics. 2017; 7(3):102-105

Muthuirulandi Sethuvel DP, Devanga Ragupathi NK, Anandan S, Walia K, Veeraraghavan B. Molecular diagnosis of non-serotypeable Shigella spp.: problems and prospects. J Med Microbiol. 2017 Feb;66(2):255-257. doi: 10.1099/jmm.0.000438. PMID: 28266285.

Mathew A, David T, Thomas K, Kuruvilla PJ, Balaji V, Jesudason MV, Samuel P. Risk factors for tuberculosis among health care workers in South India: a nested case-control study. J Clin Epidemiol. 2013 Jan;66(1):67-74. doi: 10.1016/j.jclinepi.2011.12.010. Epub 2012 Apr 20. PMID: 22521578.

Jean SS, Hsueh PR; SMART Asia-Pacific Group. Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother. 2017 Jan;72(1):166-171. doi: 10.1093/jac/dkw398. Epub 2016 Oct 4. PMID: 27703058.

Bakthavatchalam YD, Sudarsanam TD, Babu P, Munuswamy E, Muthuirulandi Sethuvel DP, Devanga Ragupathi NK, Veeraraghavan B. Methicillin-Susceptible Teicoplanin-Resistant Staphylococcus haemolyticus Isolate from a Bloodstream Infection with Novel Mutations in the tcaRAB Teicoplanin Resistance Operon. Jpn J Infect Dis. 2017 Jul 24;70(4):458-460. doi: 10.7883/yoken.JJID.2016.482. Epub 2017 Feb 28. PMID: 28250264.

Sengupta M, Prabhakar AK, Satyendra S, Thambu D, Abraham OC, Balaji V, Chen HW, Chao CC, Ching WM, Prakash JA. Utility of Loop-mediated Isothermal Amplification Assay, Polymerase Chain Reaction, and ELISA for Diagnosis of Leptospirosis in South Indian Patients. J Glob Infect Dis. 2017 Jan-Mar;9(1):3-7. doi: 10.4103/0974-777X.192967. PMID: 28250618; PMCID: PMC5330041.

Sharma P, Dahiya S, Kumari B, Balaji V, Sood S, Das BK, Kapil A. Pefloxacin as a surrogate marker for quinolone susceptibility in Salmonella enterica serovars Typhi & Paratyphi A in India. Indian J Med Res. 2017 May;145(5):687-692. doi: 10.4103/ijmr.IJMR_494_16. PMID: 28948961; PMCID: PMC5644305.

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Gajendiran R, Daniel JL, Walia K, Veeraraghavan B. First Indian report of IncX3 plasmid carrying blaNDM-7 in Escherichia coli from bloodstream infection: potential for rapid dissemination. New Microbes New Infect. 2017 Feb 2;17:65-68. doi: 10.1016/j.nmni.2017.01.012. PMID: 28337342; PMCID: PMC5350569.

Anandan S, Gopi R, Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Gunasekaran P, Walia K, Veeraraghavan B. First report of blaOXA-181-mediated carbapenem resistance in Aeromonas caviae in association with pKP3-A: Threat for rapid dissemination. J Glob Antimicrob Resist. 2017 Sep;10:310-314. doi: 10.1016/j.jgar.2017.07.006. Epub 2017 Jul 22. PMID: 28743649.

Bakthavatchalam YD, Pragasam AK, Biswas I, Veeraraghavan B. Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanisms: An update. J Glob Antimicrob Resist. 2018 Mar;12:124-136. doi: 10.1016/j.jgar.2017.09.011. Epub 2017 Sep 28. PMID: 28962863.

Bakthavatchalam YD, Pragasam AK, Biswas I, Veeraraghavan B. Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanisms: An update. J Glob Antimicrob Resist. 2018 Mar;12:124-136. doi: 10.1016/j.jgar.2017.09.011. Epub 2017 Sep 28. PMID: 28962863.

Bakthavatchalam YD, Nabarro LE, Veeraraghavan B. Evolving Rapid Methicillin-resistant Staphylococcus aureus Detection: Cover All the Bases. J Glob Infect Dis. 2017 Jan-Mar;9(1):18-22. doi: 10.4103/0974-777X.199997. PMID: 28250621; PMCID: PMC5330039.

Bakthavatchalam YD, Nabarro LEB, Ralph R, Veeraraghavan B. Diagnosis and management of Panton-Valentine leukocidin toxin associated Staphylococcus aureus infection: an update. Virulence. 2017 Aug 7:0. doi: 10.1080/21505594.2017.1362532. Epub ahead of print. PMID: 28783418.

Laishram S, Pragasam AK, Bakthavatchalam YD, Veeraraghavan B. An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies. Indian J Med Microbiol. 2017 Oct-Dec;35(4):445-468. doi: 10.4103/ijmm.IJMM_17_189. PMID: 29405135.

Sahni RD, Mathai D, Sudarsanam TD, Balaji V, Brahamadathan KN, Jesudasan MV, Lalitha MK. Extended-Spectrum Beta-lactamase Producers: Detection for the Diagnostic Laboratory. J Glob Infect Dis. 2018 Jul-Sep;10(3):140-146. doi: 10.4103/jgid.jgid_49_17. PMID: 30166813; PMCID: PMC6100337.

Pragasam AK, Shankar C, Anandan S, Verghese VP, Veeraraghavan B. Alarming increase in carbapenemase-producing Klebsiella spp causing bloodstream infections in pediatric population in India. J Infect Dev Ctries. 2017 Sep 30;11(9):736-737. doi: 10.3855/jidc.8038. PMID: 31600166.

Bakthavatchalam YD, Kumar DT, Tayubi IA, Shankar BA, Babu P, Munusamy E, Thukkaram B, Ravi R, Doss CGP, Veeraraghavan B. In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection. J Appl Microbiol. 2017 Sep;123(3):615-624. doi: 10.1111/jam.13522. PMID: 28650129.

Christopher DJ, Jeyaseelan L, Michael JS, Veeraraghavan B, Manipadam MT, David T, Gupta M, Yadav B. Burden of diabetes among patients with tuberculosis: 10-year experience from a tertiary care referral teaching hospital in South India. Lung India. 2020 May-Jun;37(3):232-237. doi: 10.4103/lungindia.lungindia_111_19. PMID: 32367845; PMCID: PMC7353927.

DOI updated on 17th Jan 2022

Veeraraghavan B, Perumalla SK, Devanga Ragupathi NK, Pragasam AK, Muthuirulandi Sethuvel DP, Inian S, Inbanathan FY. Coexistence of Fosfomycin and Colistin Resistance in Klebsiella pneumoniae: Whole-Genome Shotgun Sequencing. Genome Announc. 2016 Nov 23;4(6):e01303-16. doi: 10.1128/genomeA.01303-16. PMID: 27881539; PMCID: PMC5122681.

Veeraraghavan B, Jayaraman R, John J, Varghese R, Neeravi A, Verghese VP, Thomas K. Customized sequential multiplex PCR for accurate and early determination of invasive pneumococcal serotypes found in India. J Microbiol Methods. 2016 Nov;130:133-135. doi: 10.1016/j.mimet.2016.09.007. Epub 2016 Sep 10. PMID: 27623479.

Veeraraghavan B, Anandan S, Muthuirulandi Sethuvel DP, Puratchiveeran N, Walia K, Devanga Ragupathi NK. Molecular Characterization of Intermediate Susceptible Typhoidal Salmonella to Ciprofloxacin, and its Impact. Mol Diagn Ther. 2016 Jun;20(3):213-9. doi: 10.1007/s40291-016-0191-6. PMID: 26951258.

Vijayakumar S, Rajenderan S, Laishram S, Anandan S, Balaji V, Biswas I. Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates. Front Public Health. 2016 May 24;4:105. doi: 10.3389/fpubh.2016.00105. PMID: 27252939; PMCID: PMC4877508.

Pragasam AK, Raghanivedha M, Anandan S, Veeraraghavan B. Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile. Ann Clin Microbiol Antimicrob. 2016 Feb 24;15:12. doi: 10.1186/s12941-016-0127-3. PMID: 26911874; PMCID: PMC4765188.

Pragasam AK, Sahni RD, Anandan S, Sharma A, Gopi R, Hadibasha N, Gunasekaran P, Veeraraghavan B. A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations. J Clin Diagn Res. 2016 Jul;10(7):DC09-13. doi: 10.7860/JCDR/2016/16417.8152. Epub 2016 Jul 1. PMID: 27630840; PMCID: PMC5020186.

Veeraraghavan B, Anandan S, Sethuvel DP, Ragupathi NK. Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects. J Clin Diagn Res. 2016 Aug;10(8):DL01-2. doi: 10.7860/JCDR/2016/17022.8306. Epub 2016 Aug 1. PMID: 27656439; PMCID: PMC5028453.

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Shankar BA, Munusamy E, Anandan S, Veeraraghavan B. Draft genome sequence of blaTEM-1-mediated cephalosporin-resistant Salmonella enterica serovar Typhi from bloodstream infection. J Glob Antimicrob Resist. 2016 Dec;7:11-12. doi: 10.1016/j.jgar.2016.06.003. Epub 2016 Jul 12. PMID: 27530999.

Veeraraghavan B, Anandan S, Ragupathi NK, Vijayakumar S, Sethuvel DP, Biswas I. Draft Genome Sequence of Colistin-Resistant Acinetobacter baumannii Strain VB22595 Isolated from a Central Line-Associated Bloodstream Infection. Genome Announc. 2016 Aug 11;4(4):e00835-16. doi: 10.1128/genomeA.00835-16. PMID: 27516521; PMCID: PMC4982300.

Jean SS, Coombs G, Ling T, Balaji V, Rodrigues C, Mikamo H, Kim MJ, Rajasekaram DG, Mendoza M, Tan TY, Kiratisin P, Ni Y, Weinman B, Xu Y, Hsueh PR. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013. Int J Antimicrob Agents. 2016 Apr;47(4):328-34. doi: 10.1016/j.ijantimicag.2016.01.008. Epub 2016 Feb 17. PMID: 27005459.

Bose A, Isaac R, Balaji V, Rose W, Mohan V, Anandan S, Prasad JH, Abraham A, Krishna M, Viswanathan K. Challenges in Implementation of ANISA Protocol at the Vellore Site, India. Pediatr Infect Dis J. 2016 May;35(5 Suppl 1):S70-3. doi: 10.1097/INF.0000000000001111. PMID: 27070070.

Divyashree S, Nabarro LE, Veeraraghavan B, Rupali P. Enteric fever in India: current scenario and future directions. Trop Med Int Health. 2016 Oct;21(10):1255-1262. doi: 10.1111/tmi.12762. Epub 2016 Sep 8. PMID: 27495900.

Shankar C, Nabarro LEB, Anandan S, Veeraraghavan B. Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms? Microb Drug Resist. 2017 Jun;23(4):437-446. doi: 10.1089/mdr.2016.0043. Epub 2016 Aug 26. PMID: 27564414.

Vijayakumar S, Gopi R, Gunasekaran P, Bharathy M, Walia K, Anandan S, Veeraraghavan B. Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India. Infect Dis Ther. 2016 Sep;5(3):379-87. doi: 10.1007/s40121-016-0125-y. Epub 2016 Aug 23. PMID: 27553951; PMCID: PMC5019981.

Sahni RD, Amalanathan R, Devanga Ragupathi NK, Mathai J, Veeraraghavan B, Biswas I. Complete Genome Sequence of Serratia marcescens U36365, a Green Pigment-Producing Strain Isolated from a Patient with Urinary Tract Infection. Genome Announc. 2016 Aug 11;4(4):e00837-16. doi: 10.1128/genomeA.00837-16. PMID: 27516523; PMCID: PMC4982302.

Sharma P, Dahiya S, Balaji V, Kanga A, Panda P, Das R, Dhanraju A, Mendiratta DK, Sood S, Das BK, Kapil A. Typhoidal Salmonellae: Use of Multi-Locus Sequence Typing to Determine Population Structure. PLoS One. 2016 Sep 12;11(9):e0162530. doi: 10.1371/journal.pone.0162530. PMID: 27618626; PMCID: PMC5019401.

Krishnaraju M, Agila Kumari P, Balaji Veeraraghavan and Rama Vaidyanathan. Evaluation of cnpt-direct assay and development of a modified cnpt-edta assay to differentiate ndm from oxa-48 like carbapenemases. International Journal of Pharma and Bio Sciences. 2016;7(4):473 – 478.

Shankar C, Nabarro LE, Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Daniel JL, Doss C GP, Veeraraghavan B. Draft Genome Sequences of Three Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Isolates from Bacteremia. Genome Announc. 2016 Dec 8;4(6):e01081-16. doi: 10.1128/genomeA.01081-16. PMID: 27932638; PMCID: PMC5146430.

Veeraraghavan B, Shankar C, Vijayakumar S. Can minocycline be a carbapenem sparing antibiotic? Current evidence. Indian J Med Microbiol. 2016 Oct-Dec;34(4):513-515. doi: 10.4103/0255-0857.195380. PMID: 27934833.

Pragasam AK, Vijayakumar S, Bakthavatchalam YD, Kapil A, Das BK, Ray P, Gautam V, Sistla S, Parija SC, Walia K, Ohri VC, Anandan S, Veeraraghavan B. Molecular characterisation of antimicrobial resistance in Pseudomonas aeruginosa and Acinetobacter baumannii during 2014 and 2015 collected across India. Indian J Med Microbiol. 2016 Oct-Dec;34(4):433-441. doi: 10.4103/0255-0857.195376. PMID: 27934820.

Bakthavatchalam YD, Veeraraghavan B, Mathur P, Purighalla S, Richard VS. Polymyxin Nordmann/Poirel test for rapid detection of polymyxin resistance in Enterobacteriaceae: Indian experience. Indian J Med Microbiol. 2016 Oct-Dec;34(4):564-565. doi: 10.4103/0255-0857.195382. PMID: 27934849.

Bakthavatchalam YD, Veeraraghavan B, Peter JV, Rajinikanth J, Inbanathan FY, Devanga Ragupathi NK, Rajamani Sekar SK. Novel Observations in 11 Heteroresistant Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Strains from South India. Genome Announc. 2016 Dec 22;4(6):e01425-16. doi: 10.1128/genomeA.01425-16. PMID: 28007859; PMCID: PMC5180387.

Shankar C, Santhanam S, Kumar M, Gupta V, Devanga Ragupathi NK, Veeraraghavan B. Draft Genome Sequence of an Extended-Spectrum-β-Lactamase-Positive Hypervirulent Klebsiella pneumoniae Strain with Novel Sequence Type 2318 Isolated from a Neonate. Genome Announc. 2016 Nov 10;4(6):e01273-16. doi: 10.1128/genomeA.01273-16. PMID: 27834717; PMCID: PMC5105110.

Pragasam AK, Raghanivedha M, Anandan S, Veeraraghavan B. Molecular Characterization of Imipenem-Resistant, Meropenem-Susceptible Pseudomonas aeruginosa with blaVIM₋₂ Phenotype: Potential for Dissemination. Jpn J Infect Dis. 2016;69(2):159-60. doi: 10.7883/yoken.JJID.2015.273. Epub 2015 Nov 13. PMID: 26567829.

Yamuna D, Punithavathy PM, Sangeeta T, Balaji V. Challenges in the laboratory diagnosis and clinical management of heteroresistant Vancomycin Staphylococcus aureus (hVISA). Journal of Clinical Microbiology 2015, 4: 1-9

Bakthavatchalam YD, Anandan S, Veeraraghavan B. Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden Threat. J Glob Infect Dis. 2016 Jan-Mar;8(1):41-50. doi: 10.4103/0974-777X.176149. PMID: 27013843; PMCID: PMC4785756.

Jayaraman R, Varghese R, Kumar JL, Neeravi A, Shanmugasundaram D, Ralph R, Thomas K, Veeraraghavan B. Invasive pneumococcal disease in Indian adults: 11 years' experience. J Microbiol Immunol Infect. 2019 Oct;52(5):736-742. doi: 10.1016/j.jmii.2018.03.004. Epub 2018 May 22. PMID: 29884448.

Snyder BM, Montague BTA Link

Solaimalai D, Rathore S, Beck MM, Regi A, Yesudhason BL, Veeraraghavan B, Prakash JAJ. Enzyme-linked immunosorbent assay (ELISA) versus Venereal Disease Research Laboratory test (VDRL) and rapid plasma reagin test (RPR) for screening of syphilis in pregnant women. Int J Gynaecol Obstet. 2020 Jul;150(1):103-107. doi: 10.1002/ijgo.13154. Epub 2020 Apr 23. PMID: 32246772.

Rupali P, Palanikumar P, Shanthamurthy D, Peter JV, Kandasamy S, Zacchaeus NGP, Alexander H, Thangavelu P, Karthik R, Abraham OC, Michael JS, Paul H, Veeraraghavan B, Chacko B, Jeyaseelan V, Alangaden G, Prentiss T, Zervos MJ. Impact of an antimicrobial stewardship intervention in India: Evaluation of post-prescription review and feedback as a method of promoting optimal antimicrobial use in the intensive care units of a tertiary-care hospital. Infect Control Hosp Epidemiol. 2019 May;40(5):512-519. doi: 10.1017/ice.2019.29. PMID: 31084674.

Thomas K, Mukkai Kesavan L, Veeraraghavan B, Jasmine S, Jude J, Shubankar M, Kulkarni P, Steinhoff M; IBIS Study Group IndiaCLEN Network. Invasive pneumococcal disease associated with high case fatality in India. J Clin Epidemiol. 2013 Jan;66(1):36-43. doi: 10.1016/j.jclinepi.2012.04.006. PMID: 23177893.

Jeremiah SS, Balaji V, Anandan S, Sahni RD. A possible alternative to the error prone modified Hodge test to correctly identify the carbapenemase producing Gram-negative bacteria. Indian J Med Microbiol. 2014 Oct-Dec;32(4):414-8. doi: 10.4103/0255-0857.142258. PMID: 25297027.

Chandy SJ, Michael JS, Veeraraghavan B, Abraham OC, Bachhav SS, Kshirsagar NA. ICMR programme on Antibiotic Stewardship, Prevention of Infection & Control (ASPIC). Indian J Med Res. 2014 Feb;139(2):226-30. PMID: 24718396; PMCID: PMC4001333.

Dhaya Rani Varkey, V. Balaji, Jayanthi Abraham. Molecular Characterisation Of Extended Spectrum Beta LactamaseProducing Strains From Blood Sample. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6(3): 276-278

Balaji Veeraraghavan, Sangeeta Susan Thomas, Marilyn Mary Ninan. Diagnosis of Sepsis: How Does a Good Laboratory Respond? Journal of Patient Safety & Infection Control. 2013; 1(1): 1–5

Rajinikanth J, Balaji V, Gaikwad P, Muthusami JC. Melioidosis of the parotid: the tip of the iceberg. Otolaryngol Head Neck Surg. 2008 Nov;139(5):731-2. doi: 10.1016/j.otohns.2008.07.016. PMID: 18984274.

Mitra S, Thomas K, Balaji V, Kulkarni P and M. Steinhoff. Characteristics of Invasive Pneumococcal Disease (IPD) in Adults in South India. International Journal of Infectious Diseases. 2008; 12 (1): e230

Jesudason MV, V Balaji V, Densibai S. Toxigenicity testing of clinical isolates of non-typhoidal salmonellae in Vero cell culture & Caenorhabditis elegans model. Indian J Med Res. 2006 Jun;123(6):821-4. PMID: 16885605.

Balaji V, Jesudason MV, Sridharan G. Cytotoxin testing of environmental Aeromonas spp. in Vero cell culture. Indian J Med Res. 2004 May;119(5):186-9. PMID: 15218980.

Balaji V, Kapil A, Shastri J, Pragasam AK, Gole G, Choudhari S, Kang G, John J. Longitudinal Typhoid Fever Trends in India from 2000 to 2015. Am J Trop Med Hyg. 2018 Sep;99(3_Suppl):34-40. doi: 10.4269/ajtmh.18-0139. Epub 2018 Jul 24. PMID: 30047367; PMCID: PMC6128365.

Muthuirulandi Sethuvel DP, Subramanian N, Pragasam AK, Inbanathan FY, Gupta P, Johnson J, Sharma NC, Hemvani N, Veeraraghavan B, Anandan S, Sangal L. Insights to the diphtheria toxin encoding prophages amongst clinical isolates of Corynebacterium diphtheriae from India. Indian J Med Microbiol. 2019 Jul-Sep;37(3):423-425. doi: 10.4103/ijmm.IJMM_19_469. PMID: 32003344.

Shankar C, Pragasam AK, Veeraraghavan B, Amladi A. Bad bug, no test: Tigecycline susceptibility testing challenges and way forward. Indian J Med Microbiol. 2019 Jan-Mar;37(1):91-94. doi: 10.4103/ijmm.IJMM_19_207. PMID: 31424015.

Veeraraghavan B, Walia K. Antimicrobial susceptibility profile & resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India. Indian J Med Res. 2019 Feb;149(2):87-96. doi: 10.4103/ijmr.IJMR_214_18. Erratum in: Indian J Med Res. 2019 Mar;149(3):432. doi: 10.4103/0971-5916.261122. PMID: 31219073; PMCID: PMC6563747.

Pragasam AK, Veeraraghavan B, Anandan S, Narasiman V, Sistla S, Kapil A, Mathur P, Ray P, Wattal C, Bhattacharya S, Deotale V, Subramani K, Peter JV, Hariharan TD, Ramya I, Iniyan S, Walia K, Ohri VC. Dominance of international high-risk clones in carbapenemase-producing Pseudomonas aeruginosa: Multicentric molecular epidemiology report from India. Indian J Med Microbiol. 2018 Jul-Sep;36(3):344-351. doi: 10.4103/ijmm.IJMM_18_294. PMID: 30429385.

Vijayakumar S, Mathur P, Kapil A, Das BK, Ray P, Gautam V, Sistla S, Parija SC, Walia K, Ohri VC, Anandan S, Subramani K, Ramya I, Veeraraghavan B. Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India. Indian J Med Res. 2019 Feb;149(2):240-246. doi: 10.4103/ijmr.IJMR_2085_17. PMID: 31219089; PMCID: PMC6563728.

Shankar C, Venkatesan M, Rajan R, Mani D, Lal B, Prakash JAJ, Anandan S, Pragasam AK, Walia K, Ohri VC, Veeraraghavan B. Molecular characterization of colistin-resistant Klebsiella pneumoniae & its clonal relationship among Indian isolates. Indian J Med Res. 2019 Feb;149(2):199-207. doi: 10.4103/ijmr.IJMR_2087_17. PMID: 31219084; PMCID: PMC6563726.

Sethuvel DPM, Perumalla S, Anandan S, Michael JS, Ragupathi NKD, Gajendran R, Walia K, Veeraraghavan B. Antimicrobial resistance, virulence & plasmid profiles among clinical isolates of Shigella serogroups. Indian J Med Res. 2019 Feb;149(2):247-256. doi: 10.4103/ijmr.IJMR_2077_17. PMID: 31219090; PMCID: PMC6563743.

Bakthavatchalam YD, Arumugam A, Veeraraghavan B. An invasive marker Staphylococcus epidermidis surface protein I (SesI) harboured by a ST239 methicillin-resistant Staphylococcus aureus. J Glob Antimicrob Resist. 2019 Sep;18:122-125. doi: 10.1016/j.jgar.2019.02.006. Epub 2019 Feb 21. PMID: 30797090.

Pragasam AK, Shankar C, Veeraraghavan B, Biswas I, Nabarro LE, Inbanathan FY, George B, Verghese S. Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae Causing Bacteremia from India-A First Report. Front Microbiol. 2017 Jan 9;7:2135. doi: 10.3389/fmicb.2016.02135. PMID: 28119670; PMCID: PMC5220082. Link

Purva M, Randeep G, Rajesh M, Mahesh CM, Sunil G, Subodh K, Sushma S, Naveet W, Pramod G, Arti K, Surbhi K, Omika K, Sonal K, Manoj S, Arunaloke C, Pallab R, Manisha B, Neelam T, Priscilla R, Subaramani K, Ebor J, Veeraraghavan B, Camilla R, Vijayalakshmi N, Vibhor T, Kuldeep S, Pradeep KB, Neeraj G, Daisy K, Vimala V, Chiranjay M, Vandana KE, Muralidhar V, Vijayshri D, Ruchita A, Kanne P, Sukanya S, Chand W, Neeraj G, Sanjay B, Sourav S, Karuna T, Saurabh S, Behera B, Sanjeev S, Thirunarayan MA, Reema N, Lahri S, Raja R, Hirak JR, Sujata B, Desma D, Mammen C, Sudipta M, Manas KR, Gaurav G, Swagata T, Satyajeet M, Anupam D, Tushar SM, Bashir AF, Gulnaz B, Shaista N, Sulochana D, Khuraijam RD, Langpoklakpam CS, Padma D, Anudita B, Ujjwala G, Neeta K, Geeta V, Tanvi S, Shristi J, Prachi V, Mamta L, Prithwis B, Anil CP, Clarissa L, Rajni G, Rushika S, Lata K, Vinod O, Kamini W. Assessment of core capacities for antimicrobial stewardship practices in indian hospitals: Report from a multicentric initiative of global health security agenda. Indian J Med Microbiol. 2019 Jul-Sep;37(3):309-317. doi: 10.4103/ijmm.IJMM_19_445. PMID: 32003327.

Pragasam AK, Yesurajan F, Doss C GP, George B, Devanga Ragupathi NK, Walia K, Veeraraghavan B. Draft Genome Sequence of Extremely Drug-Resistant Pseudomonas aeruginosa (ST357) Strain CMC_VB_PA_B22862 Isolated from a Community-Acquired Bloodstream Infection. Genome Announc. 2016 Oct 20;4(5):e01092-16. doi: 10.1128/genomeA.01092-16. PMID: 27795257; PMCID: PMC5073252.

Varghese R, Neeravi A, Subramanian N, Pavithra B, Kavipriya A, Kumar JL, Girish Kumar CP, Jeyraman Y, Karthik G, Verghese VP, Veeraraghavan B. Clonal similarities and sequence-type diversity of invasive and carriage Streptococcus pneumoniae in India among children under 5 Years. Indian J Med Microbiol. 2019 Jul-Sep;37(3):358-362. doi: 10.4103/ijmm.IJMM_19_348. PMID: 32003333.

Veeraraghavan B, Lal B, Devanga Ragupathi NK, Neeravi IR, Jeyaraman R, Varghese R, Paul MM, Baskaran A, Ranjan R. First genome report on novel sequence types of Neisseria meningitidis: ST12777 and ST12778. J Glob Antimicrob Resist. 2018 Mar;12:117-118. doi: 10.1016/j.jgar.2017.11.014. Epub 2017 Dec 18. PMID: 29269053.

John AO, Paul H, Vijayakumar S, Anandan S, Sudarsan T, Abraham OC, Balaji V. Mortality from acinetobacter infections as compared to other infections among critically ill patients in South India: A prospective cohort study. Indian J Med Microbiol. 2020 Jan-Mar;38(1):24-31. doi: 10.4103/ijmm.IJMM_19_492. PMID: 32719205.

Bakthavatchalam YD, Triplicane Dwarakanathan H, Munusamy E, Jennifer L, Veeraraghavan B. A Distinct Geographic Variant of sasX in Methicillin-Resistant Staphylococcus aureus ST239 and ST368 Lineage from South India. Microb Drug Resist. 2019 Apr;25(3):413-420. doi: 10.1089/mdr.2018.0292. Epub 2019 Feb 14. PMID: 30762476.

Mitra S, Karthik R, Balaji V, George IA, Kapil A, Abraham OC. Quinolone-resistant Salmonella enterica Serovar typhi presenting as acute fulminant hepatitis. J Assoc Physicians India. 2009 Apr;57:338-9. PMID: 19702041.

Shankar C, Kumar S, Venkatesan M, Veeraraghavan B. Emergence of ST147 Klebsiella pneumoniae carrying blaNDM-7 on IncA/C2 with ompK35 and ompK36 mutations in India. J Infect Public Health. 2019 Sep-Oct;12(5):741-743. doi: 10.1016/j.jiph.2019.03.023. Epub 2019 Apr 16. PMID: 31003835.

Veeraraghavan B, Jacob JJ, Prakash JAJ, Pragasam AK, Neeravi A, Narasimman V, Anandan S. Extensive drug resistant Salmonella enterica serovar Senftenberg carrying blaNDM encoding plasmid p5558 (IncA/C) from India. Pathog Glob Health. 2019 Feb;113(1):20-26. doi: 10.1080/20477724.2019.1574112. Epub 2019 Feb 6. PMID: 30722761; PMCID: PMC6427686.

Sethuvel DPM, Anandan S, Michael JS, Murugan D, Neeravi A, Verghese VP, Walia K, Veeraraghavan B. Virulence gene profiles of Shigella species isolated from stool specimens in India: its association with clinical manifestation and antimicrobial resistance. Pathog Glob Health. 2019 Jun;113(4):173-179. doi: 10.1080/20477724.2019.1632062. Epub 2019 Jun 21. PMID: 31221039; PMCID: PMC6758641.

Vijayakumar S, Veeraraghavan B, Pragasam AK, Bakthavachalam YD. Genotyping of Acinetobacter baumannii in Nosocomial Outbreak and Surveillance. Methods Mol Biol. 2019;1946:17-22. doi: 10.1007/978-1-4939-9118-1_2. PMID: 30798540.

Veeraraghavan B, Vijayakumar S, Pragasam AK, Bakthavachalam YD, Prakash JAJ. Antimicrobial Susceptibility Testing Methods for Acinetobacter spp. Methods Mol Biol. 2019;1946:23-37. doi: 10.1007/978-1-4939-9118-1_3. PMID: 30798541.

Ravi NS, Aslam RF, Veeraraghavan B. A New Method for Determination of Minimum Biofilm Eradication Concentration for Accurate Antimicrobial Therapy. Methods Mol Biol. 2019;1946:61-67. doi: 10.1007/978-1-4939-9118-1_6. PMID: 30798544.

Ghafur A, Shankar C, GnanaSoundari P, Venkatesan M, Mani D, Thirunarayanan MA, Veeraraghavan B. Detection of chromosomal and plasmid-mediated mechanisms of colistin resistance in Escherichia coli and Klebsiella pneumoniae from Indian food samples. J Glob Antimicrob Resist. 2019 Mar;16:48-52. doi: 10.1016/j.jgar.2018.09.005. Epub 2018 Sep 20. PMID: 30244040.

Bakthavatchalam YD, Babu P, Munusamy E, Dwarakanathan HT, Rupali P, Zervos M, John Victor P, Veeraraghavan B. Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. PLoS One. 2019 Dec 30;14(12):e0227009. doi: 10.1371/journal.pone.0227009. PMID: 31887179; PMCID: PMC6936811.

Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, Ralph R. Typhoid fever: issues in laboratory detection, treatment options & concerns in management in developing countries. Future Sci OA. 2018 Jun 26;4(6):FSO312. doi: 10.4155/fsoa-2018-0003. PMID: 30057789; PMCID: PMC6060388.

Devanga Ragupathi NK, Veeraraghavan B. Data on whole genome shotgun sequencing report of clinical S. maltophilia strains from India. Data Brief. 2018 Oct 4;21:263-268. doi: 10.1016/j.dib.2018.10.005. PMID: 30364539; PMCID: PMC6197317.

Shankar C, Shankar BA, Manesh A, Veeraraghavan B. KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India. J Med Microbiol. 2018 Jul;67(7):927-930. doi: 10.1099/jmm.0.000767. Epub 2018 May 22. PMID: 29787365.

Bakthavatchalam YD, Shankar A, Thukaram B, Krishnan DN, Veeraraghavan B. Comparative evaluation of susceptibility testing methods for colistin and polymyxin B among clinical isolates of carbapenem- resistant Klebsiella pneumoniae and Acinetobacter baumannii. J Infect Dev Ctries. 2018 Jun 30;12(6):504-507. doi: 10.3855/jidc.9660. PMID: 31940304.

Bakthavatchalam YD, Ramaswamy B, Janakiraman R, Steve RJ, Veeraraghavan B. Genomic insights of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) with reduced teicoplanin susceptibility: A case of fatal necrotizing fasciitis. J Glob Antimicrob Resist. 2018 Sep;14:242-245. doi: 10.1016/j.jgar.2018.05.006. Epub 2018 May 15. PMID: 29775787.

Son S, Thamlikitkul V, Chokephaibulkit K, Perera J, Jayatilleke K, Hsueh PR, Lu CY, Balaji V, Moriuchi H, Nakashima Y, Chiu CH, Kim YJ*. A Prospective Multinational Serosurveillance Study of Bordetella pertussis Infection among 10-18 years old Asian Children and Adolescents. Clinical Microbiology and Infection. 2018 Apr 21. Link

Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. Trop Doct. 2018 Jul;48(3):182-188. doi: 10.1177/0049475518758884. Epub 2018 Mar 1. PMID: 29495943.

Shankar C, Veeraraghavan B, Nabarro LEB, Ravi R, Ragupathi NKD, Rupali P. Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection. BMC Microbiol. 2018 Jan 8;18(1):6. doi: 10.1186/s12866-017-1148-6. PMID: 29433440; PMCID: PMC5809863.

Mani SSR, Gunasekaran K, Iyyadurai R, Prakash JAJ, Veeraraghavan B, Mishra AK, Sabnis K, Victor PJ, Martin S, Chandiraseharan VK, Hansdak SG, Varghese GM. Clinical spectrum, susceptibility profile, treatment and outcome of culture-confirmed brucellosis from South India. Indian J Med Microbiol. 2018 Apr-Jun;36(2):289-292. doi: 10.4103/ijmm.IJMM_18_236. PMID: 30084427.

Khiangte HL, Vimala LR, Eapen A, Veeraraghavan B, Karuppusami R, Gibikote S. A Retrospective Case-Control Study to Evaluate the Diagnostic Accuracy of Honeycomb Sign in Melioid Liver Abscess. Am J Trop Med Hyg. 2018 Oct;99(4):852-857. doi: 10.4269/ajtmh.18-0395. PMID: 30141398; PMCID: PMC6159605.

Gopi T, Ranjith J, Anandan S, Balaji V. Epidemiological characterisation of Streptococcus pneumoniae from India using multilocus sequence typing. Indian J Med Microbiol. 2016 Jan-Mar;34(1):17-21. doi: 10.4103/0255-0857.174113. PMID: 26776113.

Vijaykumar S, Balaji V, Biswas I. Complete Genome Sequence of Acinetobacter baumannii Strain B8300, Which Displays High Twitching Motility. Genome Announc. 2015 Aug 20;3(4):e00956-15. doi: 10.1128/genomeA.00956-15. PMID: 26294640; PMCID: PMC4543518.

Vijaykumar S, Balaji V, Biswas I. Complete Genome Sequence of Acinetobacter baumannii Strain B8342, a Motility-Positive Clinical Isolate. Genome Announc. 2015 Aug 20;3(4):e00925-15. doi: 10.1128/genomeA.00925-15. PMID: 26294630; PMCID: PMC4543508.

Balaji V, Jayaraman R, Verghese VP, Baliga PR, Kurien T. Pneumococcal serotypes associated with invasive disease in under five children in India & implications for vaccine policy. Indian J Med Res. 2015 Sep;142(3):286-92. doi: 10.4103/0971-5916.166588. PMID: 26458344; PMCID: PMC4669863.

Dhiviya Prabaa MS, Shalini A, Naveen Kumar DR, Balaji V*. Identification of typical class 1 integron gene cassette in clinical isolates of MDR Shigella flexneri in south Indian population. British Microbiology Research Journal. 2015; 10(1): 1-6

Chitra C, Kumar D, Shakti L, Diana SR, Balaji V. Technical and interpretative issues of fosfomycin susceptibility testing. Indian J Med Microbiol. 2015 Oct-Dec;33(4):611-2. doi: 10.4103/0255-0857.167338. PMID: 26470984.

Shakti L, Veeraraghavan B. Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario. Indian J Med Microbiol. 2015 Oct-Dec;33(4):477-81. doi: 10.4103/0255-0857.167350. PMID: 26470951.

Laishram S, Anandan S, Devi BY, Elakkiya M, Priyanka B, Bhuvaneshwari T, Peter JV, Subramani K, Balaji V. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance. J Chemother. 2016 Aug;28(4):297-303. doi: 10.1080/1120009X.2016.1143261. PMID: 27461479.

Muthuirulandi Sethuvel DP, Anandan S, Devanga Ragupathi NK, Veeraraghavan B, Vinod O, Walia K. Association of blaCTX-M-15 and qnr genes in multidrug-resistant Salmonella Typhimurium and Shigella spp from India. J Infect Dev Ctries. 2015 Nov 30;9(11):1294-7. doi: 10.3855/jidc.6965. PMID: 26623641.

Bakthavatchalam YD, Pragasam AK, Anandan S, Joshi S, Chaudhuri BN, Chitnis DS, Roy I, Tapan D, Veeraraghavan B. Comparative in-vitro activity of ceftaroline against Staphylococcus aureus isolates from India. J Infect Dev Ctries. 2016 Jan 31;10(1):109-12. doi: 10.3855/jidc.7196. PMID: 26829546.

Rose W, Veeraraghavan B, George B. Bloodstream infections in children with febrile neutropenia: Isolates and their antimicrobial susceptibility profile. Indian J Cancer. 2015 Oct-Dec;52(4):495-6. doi: 10.4103/0019-509X.178422. PMID: 26960455.

Sengupta M, Naina P, Balaji V, Anandan S. Corynebacterium amycolatum: An Unexpected Pathogen in the Ear. J Clin Diagn Res. 2015 Dec;9(12):DD01-3. doi: 10.7860/JCDR/2015/15134.7002. Epub 2015 Dec 1. PMID: 26816893; PMCID: PMC4717710.

George Priya Doss C, Rajith B, Chakraboty C, Balaji V, Magesh R, Gowthami B, Menon S, Swati M, Trivedi M, Paul J, Vasan R, Das M. In silico profiling and structural insights of missense mutations in RET protein kinase domain by molecular dynamics and docking approach. Mol Biosyst. 2014 Mar 4;10(3):421-36. doi: 10.1039/c3mb70427k. Epub 2013 Dec 12. PMID: 24336963.

Balaji V, Sharma A, Ranjan P, Kapil A. Revised ciprofloxacin breakpoints for Salmonella Typhi: its implications in India. Indian J Med Microbiol. 2014 Apr-Jun;32(2):161-3. doi: 10.4103/0255-0857.129804. PMID: 24713903.

Pitzer VE, Bowles CC, Baker S, Kang G, Balaji V, Farrar JJ, Grenfell BT. Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study. PLoS Negl Trop Dis. 2014 Jan 9;8(1):e2642. doi: 10.1371/journal.pntd.0002642. PMID: 24416466; PMCID: PMC3886927.

Laishram S, Sahni RD, Anandan S, Balaji V. Evaluation of the antimicrobial activity of daptomycin and linezolid against vancomycin-resistant Enterococcus spp. isolates in south India. J Glob Antimicrob Resist. 2014 Sep;2(3):194-197. doi: 10.1016/j.jgar.2014.03.004. Epub 2014 Mar 28. PMID: 27873729.

Sridhar S, Grace R, Nithya PJ, Balaji V, Niranjan T, Manish K, Anil KK, Atanu JK. Group B streptococcal infection in a tertiary hospital in India--1998-2010. Pediatr Infect Dis J. 2014 Oct;33(10):1091-2. doi: 10.1097/INF.0000000000000377. PMID: 24776515.

Rajenderan S, Balaji V, Anandan S, Sahni RD, Tansarli GS, Falagas ME. Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study. PLoS One. 2014 Jul 28;9(7):e103253. doi: 10.1371/journal.pone.0103253. PMID: 25068396; PMCID: PMC4113358.

Praekelt U, Reissbrodt R, Kresse A, Pavankumar A, Sankaran K, James R, Jesudason M, Anandan S, Prakasam A, Balaji V, Dutta S, Dutta S, Ramamurthy T, Fischer R, Sander P, Schaumann R, Navarro A, Williams P. Monoclonal antibodies against all known variants of EspA: development of a simple diagnostic test for enteropathogenic Escherichia coli based on a key virulence factor. J Med Microbiol. 2014 Dec;63(Pt 12):1595-1607. doi: 10.1099/jmm.0.076323-0. Epub 2014 Sep 17. PMID: 25231626; PMCID: PMC4250835.

Valson AT, David VG, Balaji V, John GT. Multifocal bacterial osteomyelitis in a renal allograft recipient following urosepsis. Indian J Nephrol. 2014 May;24(3):189-92. doi: 10.4103/0971-4065.132022. PMID: 25120300; PMCID: PMC4127842.

Sundaram M, Veeraraghavan B, John GT. Diarrhea in a renal allograft recipient in the tropics. Transplantation. 2008 Feb 27;85(4):656. doi: 10.1097/TP.0b013e3181639d96. PMID: 18347550.

Balaji V, Rajiv K, Abraham OC. Burkholderia pseudomallei recovered in an HIV-positive individual. Indian J Med Sci. 2008 Nov;62(11):456-8. doi: 10.4103/0019-5359.48457. PMID: 19265236.

Balaji V, Thomas K, Joshi HH, Beall B. Increasing invasive disease due to penicillin resistant S. pneumoniae in India. Indian J Med Sci. 2008 Dec;62(12):492-5. doi: 10.4103/0019-5359.48554. PMID: 19265243.

Mukhopadhya A, Balaji V, Jesudason MV, Amte A, Jeyamani R, Kurian G. Isolated liver abscesses in melioidosis. Indian J Med Microbiol. 2007 Apr;25(2):150-1. doi: 10.4103/0255-0857.32724. PMID: 17582188.

Jesudason MV, Balaji V, Sirisinha S, Sridharan G. Rapid identification of Burkholderia pseudomallei in blood culture supernatants by a coagglutination assay. Clin Microbiol Infect. 2005 Nov;11(11):930-3. doi: 10.1111/j.1469-0691.2005.01235.x. PMID: 16216112.

Kerketta JA, Paul AC, Kirubakaran VB, Jesudason MV, Moses PD. Non-01 Vibrio cholerae septicemia and meningitis in a neonate. Indian J Pediatr. 2002 Oct;69(10):909-10. doi: 10.1007/BF02723720. PMID: 12450305.

Balaji V, Sridharan G, Jesudason MV. Cytotoxicity of non O1, non O139 Vibrios isolated from fresh water bodies in Vellore, south India. Indian J Med Res. 1999 Nov;110:155-9. PMID: 10680299.

Thomson CJ, Jesudason MV, Balaji V, Malathi B, Mukundan U, Amyes SG. The prevalence of Vibrio spp. in drinking water and environmental samples in Vellore South India. Epidemiol Infect. 1998 Aug;121(1):67-76. doi: 10.1017/s0950268898001010. PMID: 9747757; PMCID: PMC2809476.

John, J., Varghese, R., Lionell, J., Neeravi, A. and Veeraraghavan, B. Non-vaccine Pneumococcal Serotypes Among Children with Invasive Pneumococcal Disease Indian Pediatr; 2018, 55 (10): 874-876

Veeraraghavan B, Perumalla SK, Devanga Ragupathi NK, Pragasam AK, Muthuirulandi Sethuvel DP, Inian S, Inbanathan FY. Coexistence of Fosfomycin and Colistin Resistance in Klebsiella pneumoniae: Whole-Genome Shotgun Sequencing. Genome Announc. 2016 Nov 23;4(6):e01303-16. doi: 10.1128/genomeA.01303-16. PMID: 27881539; PMCID: PMC5122681.

Devanga Ragupathi NK, Veeraraghavan B, Muthuirulandi Sethuvel DP, Anandan S, Vasudevan K, Neeravi AR, Daniel JLK, Sathyendra S, Iyadurai R, Mutreja A. First Indian report on genome-wide comparison of multidrug-resistant Escherichia coli from blood stream infections. PLoS One. 2020 Feb 26;15(2):e0220428. doi: 10.1371/journal.pone.0220428. PMID: 32101543; PMCID: PMC7043739.

Ramanathan K, Thenmozhi M, George S, Anandan S, Veeraraghavan B, Naumova EN, Jeyaseelan L. Assessing Seasonality Variation with Harmonic Regression: Accommodations for Sharp Peaks. Int J Environ Res Public Health. 2020 Feb 18;17(4):1318. doi: 10.3390/ijerph17041318. PMID: 32085630; PMCID: PMC7068504.

Muthuirulandi Sethuvel, D. P., Anandan, S., Devanga Ragupathi, N. K., Gajendiran, R., Kuroda, M., Shibayama, K. and Veeraraghavan, B. IncFII plasmid carrying antimicrobial resistance genes in Shigella flexneri: Vehicle for dissemination J Glob Antimicrob Resist; 2018, doi:10.1016/j.jgar.2018.10.014

Balaji V, Naveen Kumar DR, Agila K. Pragasam, Francis Y, Noorjahan H, Radha G, Biju G, Indranil B. Whole Genome Sequence of Pseudomonas aeruginosa ST357 isolated from community acquired blood stream infection: PA_CMC_VB_B22862. Genome Announcement. 2016;4(5):e01092-16. Link

Maraolo AE, Corcione S, Grossi A, Signori A, Alicino C, Hussein K, Trecarichi EM, Viale P, Timsit JF, Veeraraghavan B, Villegas MV, Rahav G, Daikos GL, Vardakas KZ, Roilides E, Uhlemann AC, Ghafur AK, Mornese Pinna S, Bassetti M, Kohler PP, Giacobbe DR. The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients. Infect Dis Ther. 2021 Mar;10(1):541-558. doi: 10.1007/s40121-021-00408-8. Epub 2021 Feb 14. PMID: 33586088; PMCID: PMC7954918.

Anandan S, Peter R, Aramugam R, Ismail N, Veeraraghavan B, Kang G. Group A rotavirus gastroenteritis in older children and adults at a hospital in southern India. Vaccine. 2014 Aug 11;32 Suppl 1:A33-5. doi: 10.1016/j.vaccine.2014.03.008. PMID: 25091677.

Pragasam AK, Veeraraghavan B, Nalini E, Anandan S, Kaye KS. An update on antimicrobial resistance and the role of newer antimicrobial agents for Pseudomonas aeruginosa. Indian J Med Microbiol. 2018 Jul-Sep;36(3):303-316. doi: 10.4103/ijmm.IJMM_18_334. PMID: 30429381.

Joseph, N.A., Mathews, S.S., Anandan, S. et al. Lack of Association of Helicobacter pylori in Laryngeal Pathologies. Indian J Otolaryngol Head Neck Surg (2021). https://doi.org/10.1007/s12070-020-02361-3

Mathur, P., Veeraraghavan, B., Devanga Ragupathi, N. K., Inbanathan, F. Y., Khurana, S., Bhardwaj, N., Kumar, S., Sagar, S. and Gupta, A. Multiple mutations in lipid-A modification pathway & novel fosA variants in colistin-resistant Klebsiella pneumoniae Future Sci OA; 2018, 4 (7): FSO319 Link

Vasudevan K, Devanga Ragupathi NK, Jacob JJ, Veeraraghavan B. Highly accurate-single chromosomal complete genomes using IonTorrent and MinION sequencing of clinical pathogens. Genomics. 2020 Jan;112(1):545-551. doi: 10.1016/j.ygeno.2019.04.006. Epub 2019 Apr 10. PMID: 30978388.

Sam AS, Ninan MM, Ranjani R, Devanga Raghupathi NK, Balaji V, Michael JS. Nontuberculous mycobacteria - clinical and laboratory diagnosis: experiences from a TB endemic country. Future Sci OA. 2020 Jul 30;6(9):FSO612. doi: 10.2144/fsoa-2020-0023. PMID: 33235807; PMCID: PMC7668123.

Shankar C, Kumar M, Baskaran A, Paul MM, Ponmudi N, Santhanam S, Michael JS, Veeraraghavan B. Molecular characterisation for clonality and transmission dynamics of an outbreak of Klebsiella pneumoniae amongst neonates in a tertiary care centre in South India. Indian J Med Microbiol. 2018 Jan-Mar;36(1):54-60. doi: 10.4103/ijmm.IJMM_17_426. PMID: 29735827.

Walia K, Madhumathi J, Veeraraghavan B, Chakrabarti A, Kapil A, Ray P, Singh H, Sistla S, Ohri VC. Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far. Indian J Med Res. 2019 Feb;149(2):164-179. doi: 10.4103/ijmr.IJMR_226_18. PMID: 31219080; PMCID: PMC6563732.

George J, Chandy VJ, Premnath J, Hariharan TD, Oommen AT, Balaji V, Poonnoose PM. Microbiological profile of septic arthritis in adults: Lessons learnt and treatment strategies. Indian J Med Microbiol. 2019 Jan-Mar;37(1):29-33. doi: 10.4103/ijmm.IJMM_19_134. PMID: 31424007.

Ravi NS, Anandan S, Vijayakumar S, Gopi R, Lopes BS, Veeraraghavan B. The potential of different molecular biology methods in tracking clones of Acinetobacter baumannii in an ICU setting. J Med Microbiol. 2018 Sep;67(9):1340-1347. doi: 10.1099/jmm.0.000797. Epub 2018 Jul 17. PMID: 30016226.

Dhiviya Prabaa MS, Naveen Kumar DR, Yesurajan IF, Anandan S, Kamini W, Balaji V. Identification of nonserotypeable Shigella spp. using genome sequencing: a step forward. Future Sci OA. 2017 Jul 7;3(4):FSO229. doi: 10.4155/fsoa-2017-0063. PMID: 29134117; PMCID: PMC5674244.

Sharma NC, Anandan S, Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Vasudevan K, Kumar D, Gupta SK, Sangal L, Veeraraghavan B. Genetic Diversity of Clinical Bordetella Pertussis ST2 Strains in comparison with Vaccine Reference Strains of India. J Genomics. 2021 Sep 3;9:38-42. doi: 10.7150/jgen.58823. PMID: 34527084; PMCID: PMC8437686.

Napolean M, Rosemol V, John M, Varghese AM, Periyasamy J, Balaji V, Naina P. Nasopharyngeal colonization of otopathogens in South Indian children with acute otitis media - A case control pilot study. J Otol. 2021 Oct;16(4):220-224. : 10.1016/j.joto.2021.02.004. Epub 2021 Mar 4. PMID: 34548867; PMCID: PMC8438633.

Nakamura T, Cohen AL, Schwartz S, Mwenda JM, Weldegebriel G, Biey JNM, Katsande R, Ghoniem A, Fahmy K, Rahman HA, Videbaek D, Daniels D, Singh S, Wasley A, Rey-Benito G, de Oliveira L, Ortiz C, Tondo E, Liyanage JBL, Sharifuzzaman M, Grabovac V, Batmunkh N, Logronio J, Heffelfinger J, Fox K, De Gouveia L, von Gottberg A, Du Plessis M, Kwambana-Adams B, Antonio M, El Gohary S, Azmy A, Gamal A, Voropaeva E, Egorova E, Urban Y, Duarte C, Veeraraghavan B, Saha S, Howden B, Sait M, Jung S, Bae S, Litt D, Seaton S, Slack M, Antoni S, Ouattara M, Van Beneden C, Serhan F.  The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019. J Infect Dis. 2021 Sep 1;224(Supplement_3):S161-S173. doi: 10.1093/infdis/jiab217. PMID: 34469555; PMCID: PMC8409679.

Kulkarni AP, Nagvekar VC, Veeraraghavan B, Warrier AR, Ts D, Ahdal J, Jain R. Current Perspectives on Treatment of Gram-Positive Infections in India: What Is the Way Forward? Interdiscip Perspect Infect Dis. 2019 Apr 7;2019:7601847. doi: 10.1155/2019/7601847. PMID: 31080476; PMCID: PMC6475552.

Balaji V, Perumalla S, Perumal R, Inbanathan FY, Rajamani Sekar SK, Paul MM, Sahni RD, Prakash JAJ, Iyadurai R Multi locus sequence typing of Burkholderia pseudomallei isolates from India unveils molecular diversity and confers regional association in Southeast Asia. PLoS Negl Trop Dis. 2018 Jun 27;12(6):e0006558. doi: 10.1371/journal.pntd.0006558. PMID: 29949580; PMCID: PMC6053238.

George B, Kulkarni U, Lionel S, Devasia AJ, Aboobacker FN, Lakshmi KM, Selvarajan S, Korula A, Rose W, Varghese GM, Rupali P, Veeraraghavan B, Michael JS, Abraham A, Abraham A, Mathews V. Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications-A single center experience from India. Transplant Cell Ther. 2022 Jan;28(1):45.e1-45.e8. doi: 10.1016/j.jtct.2021.09.020. Epub 2021 Oct 2. PMID: 34607073.

Jacob A, Iyadurai R, Punitha JV, Chacko B, Jasmine S, Bharathy M, Mathew D, Veeraraghavan B. Stenotrophomonas isolates in a tertiary care centre in South India. Indian J Med Microbiol. 2021 Nov 19:S0255-0857(21)04708-3. doi: 10.1016/j.ijmmb.2021.11.004. Epub ahead of print. PMID: 34810033.

Jacob, JJ. Priya, T. Solaimalai, D. Yesudoss, M. Malaiyappan, JR. Rachel, T. Aravind, v. Priya, M. George, B . Veeraraghavan, B Draft genome sequences data of rare Salmonella enterica sub sp. enterica serovar Ceyco and serovar Hillegersberg isolated from diarrheal patients in India Data in Brief Volume 41, April 2022, 107875. doi.org/10.1016/j.dib.2022.107875

Srinivasan M, Sindhu KN, Kumar SJ, Abraham P, Anandan S, Balaji V, Mohan VR, Kang G, John J. Hepatitis A Outbreak with the Concurrence of Salmonella Typhi and Salmonella Poona Infection in Children of Urban Vellore, South India. Am J Trop Med Hyg. 2020 Jun;102(6):1249-1252. doi: 10.4269/ajtmh.19-0742. PMID: 32228778; PMCID: PMC7253137.

Veeraraghavan B, Bakthavatchalam YD, Soman R, Swaminathan S, Manesh A, Nagvekar V, Nangia V. Management of serious infections caused by metallo β-lactamases with or without OXA-48-like expressing Enterobacterales with aztreonam and ceftazidime/avibactam combination: Dosing strategy for better clinical outcome. Indian J Med Microbiol. 2021 Jul;39(3):286-288. doi: 10.1016/j.ijmmb.2021.04.002. Epub 2021 Apr 21. PMID: 33892973.

Amladi A, Devanga Ragupathi NK, Vasudevan K, Venkatesan M, Anandan S, Veeraraghavan B. First report of Burkholderia pseudomallei ST412 and ST734 clones harbouring blaOXA-57 but susceptible to imipenem in India. New Microbes New Infect. 2019 Oct 15;32:100613. doi: 10.1016/j.nmni.2019.100613. PMID: 31737280; PMCID: PMC6849412.

Bakthavatchalam YD, Mukhopadhyay C, Veeraraghavan B. Management of Burkholderia pseudomallei infections: Recent recommendations on antimicrobial susceptibility testing. Indian J Med Microbiol. 2021 Nov 9:S0255-0857(21)04696-X. doi: 10.1016/j.ijmmb.2021.10.007. Epub ahead of print. PMID: 34772537.

Bathavatchalam YD, Solaimalai D, Amladi A, Dwarakanathan HT, Anandan S, Veeraraghavan B. Vancomycin heteroresistance in Staphylococcus haemolyticus: elusive phenotype. Future Sci OA. 2021 Apr 9;7(7):FSO710. doi: 10.2144/fsoa-2020-0179. PMID: 34258023; PMCID: PMC8256318.

Soman R, Bakthavatchalam YD, Nadarajan A, Dwarakanathan HT, Venkatasubramanian R, Veeraraghavan B. Is it time to move away from polymyxins?: evidence and alternatives. Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):461-475. doi: 10.1007/s10096-020-04053-w. Epub 2020 Oct 2. PMID: 33009595

Molander V, Elisson C, Balaji V, Backhaus E, John J, Vargheese R, Jayaraman R, Andersson R. Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes. BMC Infect Dis. 2013 Nov 9;13:532. doi: 10.1186/1471-2334-13-532. PMID: 24206667; PMCID: PMC3827497.

Bakthavatchalam YD, Vasudevan K, Babu P, Neeravi AR, Narasiman V, Veeraraghavan B. Genomic insights of optrA-carrying linezolid-resistant Enterococcus faecium using hybrid assembly: first report from India. J Glob Antimicrob Resist. 2021 Jun;25:331-336. doi: 10.1016/j.jgar.2021.04.005. Epub 2021 May 4. PMID: 33957286.

Jayaraman Y, Veeraraghavan B, Girish Kumar CP, Sukumar B, Rajkumar P, Kangusamy B, Verghese VP, Varghese R, Jayaraman R, Kapoor AN, Gupta N, Kanagasabai K, David JK, Rajaraman J, Sockalingam G, Khera A, Haldar P, Aggarwal MK, Pillai RK, Manchanda V, Theodore RBJ, Rajahamsan J, Mohan G, Jayalekshmi V, Nedunchelian K, Devasena N, Sridharan S, Selvi R, Ravinder T, Narayana Babu R, Mathevan G, Sugumari C, Sugandhi Rao P, Kini PG, Dwibedi B, Kanga A, Grover N, Narayanan H, Mehendale SM. Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India. Vaccine. 2021 Jun 23;39(28):3737-3744. doi: 10.1016/j.vaccine.2021.05.041. Epub 2021 May 29. PMID: 34074545.

Shankar C, Basu S, Lal B, Shanmugam S, Vasudevan K, Mathur P, Ramaiah S, Anbarasu A, Veeraraghavan B. Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae: In Silico and In Vitro Evidence. Front Cell Infect Microbiol. 2021 Sep 13;11:709681. doi: 10.3389/fcimb.2021.709681. PMID: 34589442; PMCID: PMC8473682.

Veeraraghavan B, Bakthavatchalam YD, Sahni RD. Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy. Infect Dis Ther. 2021 Mar;10(1):15-25. doi: 10.1007/s40121-020-00374-7. Epub 2020 Dec 11. PMID: 33306184; PMCID: PMC7954971.

Bakthavatchalam YD, Routray A, Mane A, Kamat S, Gupta A, Bari AK, Rohit A, Poojary A, Mukherjee DN, Sethuraman N, Munshi N, Shah S, Balaji V, Gupta Y. In vitro activity of Ceftazidime-Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019. Diagn Microbiol Infect Dis. 2022 May;103(1):115652. doi: 10.1016/j.diagmicrobio.2022.115652. Epub 2022 Jan 31. PMID: 35255290.

Basu S, Naha A, Veeraraghavan B, Ramaiah S, Anbarasu A. In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis. J Cell Biochem. 2022 Jan;123(1):115-127. doi: 10.1002/jcb.29953. Epub 2021 May 17. PMID: 33998043.

Murugesan M, Ranjan J, Devanga Ragupathi NK, Michael JS, Viggeswarpu S, Wilson BP, Veeraraghavan B. Diagnostic methods and identification challenges experienced in a Burkholderia contaminans outbreak occurred in a tertiary care centre. Indian J Med Microbiol. 2021 Apr;39(2):192-195. doi: 10.1016/j.ijmmb.2020.10.023. Epub 2020 Nov 3. PMID: 33966861.

Varghese R, Neeravi A, Jacob JJ, Vasudevan K, Kumar JL, Subramanian N, Veeraraghavan B. Comparative genomics of invasive Streptococcus pneumoniae CC320/271 serotype 19F/19A before the introduction of pneumococcal vaccine in India. Mol Biol Rep. 2021 Apr;48(4):3265-3276. doi: 10.1007/s11033-021-06353-6. Epub 2021 Apr 19. PMID: 33876375.

Varghese R, Basu S, Neeravi A, Pragasam A, Aravind V, Gupta R, Miraclin A, Ramaiah S, Anbarasu A, Veeraraghavan B. Emergence of Meropenem Resistance Among Cefotaxime Non-susceptible Streptococcus pneumoniae: Evidence and Challenges. Front Microbiol. 2022 Feb 3;12:810414. doi: 10.3389/fmicb.2021.810414. PMID: 35185834; PMCID: PMC8853538.

Agrawal V, Valson AT, Bakthavatchalam YD, Kakde S, Mohapatra A, David VG, Alexander S, Jacob S, Jude Prakash JA, Veeraraghavan B, Varughese S. Skin Colonizers and Catheter Associated Blood Stream Infections in Incident Indian Dialysis Patients. Indian J Nephrol. 2022 Jan-Feb;32(1):34-41. doi: 10.4103/ijn.IJN_400_20. Epub 2021 Apr 8. PMID: 35283564; PMCID: PMC8916144.

Bakthavatchalam YD, Puraswani M, Livingston A, Priya M, Venkatesan D, Sharma D, Iyadurai R, Pichamuthu K, Veeraraghavan B, Mathur P. Novel linear plasmids carrying vanA cluster drives the spread of vancomycin resistance in Enterococcus faecium in India. J Glob Antimicrob Resist. 2022 Mar 23;29:168-172. doi: 10.1016/j.jgar.2022.03.013. Epub ahead of print. PMID: 35339734.

Basu S, Naha A, Veeraraghavan B, Ramaiah S, Anbarasu A. In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis. J Cell Biochem. 2022 Jan;123(1):115-127. doi: 10.1002/jcb.29953. Epub 2021 May 17. PMID: 33998043.

Shankar C, Vasudevan K, Jacob JJ, Baker S, Isaac BJ, Neeravi AR, Sethuvel DPM, George B, Veeraraghavan B. Hybrid Plasmids Encoding Antimicrobial Resistance and Virulence Traits Among Hypervirulent Klebsiella pneumoniae ST2096 in India. Front Cell Infect Microbiol. 2022 Apr 27;12:875116. doi: 10.3389/fcimb.2022.875116. PMID: 35573787; PMCID: PMC9094440.

Sahni RD, Balaji V, Varghese R, John J, Tansarli GS, Falagas ME. Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: a prospective study. Future Microbiol. 2013 May;8(5):675-80. doi: 10.2217/fmb.13.31. PMID: 23642120.

Francis MR, Roy S, Sarkar R, Balraj V, Kang G. Evaluation of a commercially available polyvinylidene fluoride membrane filtration system for water decontamination. Indian J Med Microbiol. 2013 Jan-Mar;31(1):97-8. doi: 10.4103/0255-0857.108758. PMID: 23508447.

Veeraraghavan, Balaji & Shankar, Chaitra & Vijayakumar, Saranya & Ragothaman, Harthi & Shankar, Abirami & Lal, Binesh & Manesh, Abi. In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 58. 21002776. 10.1016/j.ijantimicag.2021.106421.6.

Mathew G, George AS, Deepthi RV, Rose W, Verghese VP, Varghese R, Veeraraghavan B, Agarwal I. Epidemiology and outcomes of pneumococcal sepsis in children with nephrotic syndrome in a developing country. Pediatr Nephrol. 2022 Apr 14:1–7. doi: 10.1007/s00467-022-05550-0. Epub ahead of print. PMID: 35425998; PMCID: PMC9009986.

Samson D, Rupa V, Veeraraghavan B, Varghese R, Isaac R, L J. Follow up of a birth cohort to identify prevalence and risk factors for otitis media among Indian children in the eighth year of life. Int J Pediatr Otorhinolaryngol. 2020 Oct;137:110201. doi: 10.1016/j.ijporl.2020.110201. Epub 2020 Jul 10. PMID: 32658800.

Giri A, Karkey A, Dongol S, Arjyal A, Maharjan A, Veeraraghavan B, Paudyal B, Dolecek C, Gajurel D, Phuong DNT, Thanh DP, Qamar F, Kang G, Hien HV, John J, Lawson K, Wolbers M, Hossain MS, Sharifuzzaman M, Luangasanatip N, Maharjan N, Olliaro P, Rupali P, Shakya R, Shakoor S, Rijal S, Qureshi S, Baker S, Joshi S, Ahmed T, Darton T, Bao TN, Lubell Y, Kestelyn E, Thwaites G, Parry CM, Basnyat B. Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of clinically suspected or confirmed uncomplicated typhoid fever in South Asia: a randomised controlled trial protocol. Wellcome Open Res. 2021 Nov 12;6:207. doi: 10.12688/wellcomeopenres.16801.2. PMID: 35097222; PMCID: PMC8772527.

Veeraraghavan B, Bakthavatchalam YD, Kandasamy S, Iyadurai R. Clinical efficacy of novel combinations of older beta-lactam and beta-lactamase inhibitors: Where are the evidences? Indian J Med Microbiol. 2021 Dec 28:S0255-0857(21)04725-3. doi: 10.1016/j.ijmmb.2021.12.005. Epub ahead of print. PMID: 34972570.

Palwe S, Bakthavatchalam YD, Khobragadea K, Kharat AS, Walia K, Veeraraghavan B. In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations. Antibiotics (Basel). 2021 Oct 29;10(11):1318. doi: 10.3390/antibiotics10111318. PMID: 34827256; PMCID: PMC8614831.

Balaji V, Rajenderan S, Anandan S, Biswas I. Genome Sequences of Two Multidrug-Resistant Acinetobacter baumannii Clinical Strains Isolated from Southern India. Genome Announc. 2015 Sep 10;3(5):e01010-15. doi: 10.1128/genomeA.01010-15. PMID: 26358595; PMCID: PMC4566177.

Samajpati S, Pragasam AK, Mandal S, Balaji V, Dutta S. Emergence of ceftriaxone resistant Salmonella enterica serovar Typhi in Eastern India. Infect Genet Evol. 2021 Dec;96:105093. doi: 10.1016/j.meegid.2021.105093. Epub 2021 Sep 27. PMID: 34592414.

Varghese R, Veeraraghavan B. Decoding the Penicillin Resistance of Streptococcus pneumoniae for Invasive and Noninvasive Infections. Microb Drug Resist. 2021 Jul;27(7):942-950. doi: 10.1089/mdr.2020.0233. Epub 2020 Sep 30. PMID: 32996825.

Jacob JJ, Pragasam AK, Vasudevan K, Veeraraghavan B, Kang G, John J, Nagvekar V, Mutreja A. Salmonella Typhi acquires diverse plasmids from other Enterobacteriaceae to develop cephalosporin resistance. Genomics. 2021 Jul;113(4):2171-2176 . doi: 10.1016/j.ygeno.2021.05.003. Epub 2021 May 12. PMID: 33965548; PMCID: PMC8276774.

Basu S, Naha A, Veeraraghavan B, Ramaiah S, Anbarasu A. In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis. J Cell Biochem. 2022 Jan;123(1):115-127. doi: 10.1002/jcb.29953. Epub 2021 May 17. PMID: 33998043.

Mathew SK, Rao SV, Prabha R, Neely MN, Mathew BS, Aruldhas BW, Veeraraghavan B, Kandasamy S. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients. J Clin Pharmacol. 2023 Jan;63(1):57-65. doi: 10.1002/jcph.2130. Epub 2022 Aug 24. PMID: 35924629.

Chang FY, Chuang YC, Veeraraghavan B, Apisarnthanarak A, Tayzon MF, Kwa AL, Chiu CH, Deris ZZ, Amir Husin S, Hashim H, Karuniawati A, Ahmed A, Matsumoto T, Nguyen VK, Dinh TTH. Gaps in antimicrobial stewardship programmes in Asia: a survey of 10 countries. JAC Antimicrob Resist. 2022 Nov 23;4(6):dlac117. doi: 10.1093/jacamr/dlac117. PMID: 36439993; PMCID: PMC9683392.

George B, Kulkarni U, Lionel S, Devasia AJ, Aboobacker FN, Lakshmi KM, Selvarajan S, Korula A, Rose W, Varghese GM, Rupali P, Veeraraghavan B, Michael JS, Abraham A, Abraham A, Mathews V. Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications-A single center experience from India. Transplant Cell Ther. 2022 Jan;28(1):45.e1-45.e8. doi: 10.1016/j.jtct.2021.09.020. Epub 2021 Oct 2. PMID: 34607073.

Bakthavatchalam YD, Basu S, Shankar A, Ramaiah S, Anbarasu A, Veeraraghavan B. Genomics and structural insight into the masking of gentamicin-resistance in clinical Burkholderia pseudomallei strain VB29710 from India. Diagn Microbiol Infect Dis. 2022 Dec 6;105(3):115878. doi: 10.1016/j.diagmicrobio.2022.115878. Epub ahead of print. PMID: 36529021.

Khokhar F, Pickard D, Dyson Z, Iqbal J, Pragasam A, John JJ, Veeraraghavan B, Qamar F, Dougan G, MacQueen H, Rigas S, Holmes M, Mutreja A. Multiplex PCR assay to detect high risk lineages of Salmonella Typhi and Paratyphi A. PLoS One. 2022 Jul 22;17(7):e0267805. doi: 10.1371/journal.pone.0267805. PMID: 35867662; PMCID: PMC9307194.

Mathur P, Malpiedi P, Walia K, Srikantiah P, Gupta S, Lohiya A, Chakrabarti A, Ray P, Biswal M, Taneja N, Rupali P, Balaji V, Rodrigues C, Lakshmi Nag V, Tak V, Venkatesh V, Mukhopadhyay C, Deotale V, Padmaja K, Wattal C, Bhattacharya S, Karuna T, Behera B, Singh S, Nath R, Ray R, Baveja S, Fomda BA, Sulochana Devi K, Das P, Khandelwal N, Verma P, Bhattacharyya P, Gaind R, Kapoor L, Gupta N, Sharma A, VanderEnde D, Siromany V, Laserson K, Guleria R; Indian Healthcare Associated Infection Surveillance Network collaborators. Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: a multicentre, hospital-based, prospective surveillance study. Lancet Glob Health. 2022 Sep;10(9):e1317-e1325. doi: 10.1016/S2214-109X(22)00274-1. PMID: 35961355.

Madhumathi J, Sinha R, Veeraraghavan B, Walia K. Use of "Social Media"-an Option for Spreading Awareness in Infection Prevention. Curr Treat Options Infect Dis. 2021 Jan 23:1-18. doi: 10.1007/s40506-020-00244-3. Epub ahead of print. PMID: 33519303; PMCID: PMC7826144.

Veeraraghavan B, Bakthavatchalam YD, Sahni RD. Oral Antibiotics in Clinical Development for Community-Acquired Urinary Tract Infections. Infect Dis Ther. 2021 Dec;10(4):1815-1835. doi: 10.1007/s40121-021-00509-4. Epub 2021 Aug 6. PMID: 34357517; PMCID: PMC8572892.

Jacob JJ, Veeraraghavan B, Vasudevan K. Metagenomic next-generation sequencing in clinical microbiology. Indian J Med Microbiol. 2019 Apr-Jun;37(2):133-140. doi: 10.4103/ijmm.IJMM_19_401. PMID: 31745012.

Vijayakumar S, Jacob JJ, Vasudevan K, Mathur P, Ray P, Neeravi A, Baskaran A, Kirubananthan A, Anandan S, Biswas I, Walia K, Veeraraghavan B. Genomic Characterization of Mobile Genetic Elements Associated With Carbapenem Resistance of Acinetobacter baumannii From India. Front Microbiol. 2022 Jun 15;13:869653. doi: 10.3389/fmicb.2022.869653. PMID: 35783393; PMCID: PMC9240704.

Sahni RD, Veeraraghavan B, Dhiviya Prabaa MS, Jacob JJ. Will the recently reinstated clsi 2020 breakpoints of norfloxacin for urinary isolates work for India? - Tertiary care experience and evidence. Indian J Med Microbiol. 2019 Oct-Dec;37(4):600-601. doi: 10.4103/ijmm.IJMM_20_142. PMID: 32436890.

Bakthavatchalam YD, Elangovan D, Jaganathan SV, Subburaju N, Shankar A, Manokaran Y, J S, Devi R, Baveja S, Devi S, S J, Bhattacharya S, S M R, Yesudhason B, Shetty V, Mutreja A, Manesh A, Varghese GM, Marwick CA, Parcell BJ, Gilbert IH, Veeraraghavan B. In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in India. Microbiol Spectr. 2023 Feb 27:e0492522. doi: 10.1128/spectrum.04925-22. Epub ahead of print. PMID: 36847537.

Shankar C, Jacob JJ, Vasudevan K, Biswas R, Manesh A, Sethuvel DPM, Varughese S, Biswas I, Veeraraghavan B. Emergence of Multidrug Resistant Hypervirulent ST23 Klebsiella pneumoniae: Multidrug Resistant Plasmid Acquisition Drives Evolution. Front Cell Infect Microbiol. 2020 Nov 20;10:575289. doi: 10.3389/fcimb.2020.575289. PMID: 33330125; PMCID: PMC7718023.

Shankar C, Jacob JJ, Vasudevan K, Biswas R, Manesh A, Sethuvel DPM, Varughese S, Biswas I, Veeraraghavan B. Emergence of Multidrug Resistant Hypervirulent ST23 Klebsiella pneumoniae: Multidrug Resistant Plasmid Acquisition Drives Evolution. Front Cell Infect Microbiol. 2020 Nov 20;10:575289. doi: 10.3389/fcimb.2020.575289. PMID: 33330125; PMCID: PMC7718023.

Jacob JJ, John Fletcher G, Monisha Priya T, Veeraraghavan B, Mutreja A. Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics. Indian J Med Microbiol. 2021 Oct-Dec;39(4):417-422. doi: 10.1016/j.ijmmb.2021.08.001. Epub 2021 Aug 26. PMID: 34454775; PMCID: PMC8387243.

Vijay S, Bansal N, Rao BK, Veeraraghavan B, Rodrigues C, Wattal C, Goyal JP, Tadepalli K, Mathur P, Venkateswaran R, Venkatasubramanian R, Khadanga S, Bhattacharya S, Mukherjee S, Baveja S, Sistla S, Panda S, Walia K. Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience. Infect Drug Resist. 2021 May 24;14:1893-1903. doi: 10.2147/IDR.S299774. PMID: 34079300 PMCID: PMC8164345.

Madhuri V, Santhanam M, Rajagopal K, Sugumar LK, Balaji V. WISP3 mutational analysis in Indian patients diagnosed with progressive pseudorheumatoid dysplasia and report of a novel mutation at p.Y198. Bone Joint Res. 2016 Jul;5(7):301-6. doi: 10.1302/2046-3758.57.2000520. PMID: 27436824; PMCID: PMC4957178.

Palwe S, Bakthavatchalam YD, Khobragadea K, Kharat AS, Walia K, Veeraraghavan B. In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations. Antibiotics (Basel). 2021 Oct 29;10(11):1318. doi: 10.3390/antibiotics10111318. PMID: 34827256; PMCID: PMC8614831.

N N, C GP, Chakraborty C, V K, D TK, V B, R S, Lu A, Ge Z, Zhu H. Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: An integrated computational approach. Sci Rep. 2016 Jul 29;6:30106. doi: 10.1038/srep30106. PMID: 27471101; PMCID: PMC4965867.

Muthuirulandi Sethuvel DP, Mutreja A, Pragasam AK, Vasudevan K, Murugan D, Anandan S, Michael JS, Walia K, Veeraraghavan B. Phylogenetic and Evolutionary Analysis Reveals the Recent Dominance of Ciprofloxacin-Resistant Shigella sonnei and Local Persistence of S. flexneri Clones in India. mSphere. 2020 Oct 7;5(5):e00569-20. doi: 10.1128/mSphere.00569-20. PMID: 33028681; PMCID: PMC7568650.

Veeraraghavan B, Poojary A, Shankar C, Bari AK, Kukreja S, Thukkaram B, Neethimohan RG, Bakhtavachalam YD, Kamat S. In-vitro activity of tigecycline and comparator agents against common pathogens: Indian experience. J Infect Dev Ctries. 2019 Mar 31;13(3):245-250. doi: 10.3855/jidc.10376. PMID: 32040455.

Basu S, Varghese R, Debroy R, Ramaiah S, Veeraraghavan B, Anbarasu A. Non-steroidal anti-inflammatory drugs ketorolac and etodolac can augment the treatment against pneumococcal meningitis by targeting penicillin-binding proteins. Microb Pathog. 2022 Sep;170:105694. doi: 10.1016/j.micpath.2022.105694. Epub 2022 Jul 31. PMID: 35921951.

Murugesan M, Raveendran R, Kannangai R, Ramasamy J, Ray P, Gope M, Natarajan V, Walia K, Wattal C, Veeraraghavan B. Indian microbiology EQAS registered laboratory's capacity building and infection control practices during the COVID-19 pandemic in India: Lessons learnt and gaps identified. Indian J Med Microbiol. 2023 May-Jun;43:51-57. doi: 10.1016/j.ijmmb.2022.09.009. Epub 2022 Oct 17. PMID: 36266150 PMCID: PMC9576257.

Sethuvel DPM, Bakthavatchalam YD, Karthik M, Irulappan M, Shrivastava R, Periasamy H, Veeraraghavan B. β-Lactam Resistance in ESKAPE Pathogens Mediated Through Modifications in Penicillin-Binding Proteins: An Overview. Infect Dis Ther. 2023 Mar;12(3):829-841. doi: 10.1007/s40121-023-00771-8. Epub 2023 Mar 6. PMID: 36877435; PMCID: PMC10017896.

Bakthavatchalam YD, Shankar A, Muthuirulandi Sethuvel DP, Asokan K, Kanthan K, Veeraraghavan B. Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence. Future Sci OA. 2020 Feb 26;6(4):FSO461. doi: 10.2144/fsoa-2019-0074. PMID: 32257374; PMCID: PMC7117555.

Bhagwat SS, Hariharan P, Joshi PR, Palwe SR, Shrivastava R, Patel MV, Devanga Ragupathi NK, Bakthavatchalam YD, Ramesh MS, Soman R, Veeraraghavan B. Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3. J Antimicrob Chemother. 2020 Dec 1;75(12):3563-3567. doi: 10.1093/jac/dkaa353. PMID: 32772098.

Veeraraghavan B, Bakthavatchalam YD, Manesh A, Lal B, Swaminathan S, Ansari A, Subbareddy K, Rangappa P, Choudhuri AH, Nagvekar V, Mehta Y, Appalaraju B, Baveja S, Baliga S, Shenoy S, Bhardwaj R, Kongre V, Dattatraya GS, Verma B, Mukherjee DN, Gupta S, Shanmugam P, Iravane J, Mishra SR, Barman P, Chopra S, Hariharan M, Surpam R, Pratap R, Turbadkar D, Taklikar S; Drug Discovery group, Wockhardt. India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care. Indian J Med Microbiol. 2023 Jan-Feb;41:71-80. doi: 10.1016/j.ijmmb.2022.11.005. Epub 2022 Dec 9. PMID: 36509611.

Pragasam AK, Veeraraghavan B, Shankar BA, Bakthavatchalam YD, Mathuram A, George B, Chacko B, Korula P, Anandan S. Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from In vitro study. Indian J Med Microbiol. 2019 Jan-Mar;37(1):34-41. doi: 10.4103/ijmm.IJMM_19_189. PMID: 31424008.

Kumar N, Miraclin AT, Gunasekaran K, Veeraraghavan B. Invasive Listeriosis: Molecular Determinants of Virulence and Antimicrobial Resistance. J Glob Infect Dis. 2022 Aug 26;14(3):125-127. doi: 10.4103/jgid.jgid_94_22. PMID: 36237563; PMCID: PMC9552339.

Jacob JJ, John Fletcher G, Monisha Priya T, Veeraraghavan B, Mutreja A. Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics. Indian J Med Microbiol. 2021 Oct-Dec;39(4):417-422. doi: 10.1016/j.ijmmb.2021.08.001. Epub 2021 Aug 26. PMID: 34454775; PMCID: PMC8387243.

Nakamura T, Cohen AL, Schwartz S, Mwenda JM, Weldegebriel G, Biey JNM, Katsande R, Ghoniem A, Fahmy K, Rahman HA, Videbaek D, Daniels D, Singh S, Wasley A, Rey-Benito G, de Oliveira L, Ortiz C, Tondo E, Liyanage JBL, Sharifuzzaman M, Grabovac V, Batmunkh N, Logronio J, Heffelfinger J, Fox K, De Gouveia L, von Gottberg A, Du Plessis M, Kwambana-Adams B, Antonio M, El Gohary S, Azmy A, Gamal A, Voropaeva E, Egorova E, Urban Y, Duarte C, Veeraraghavan B, Saha S, Howden B, Sait M, Jung S, Bae S, Litt D, Seaton S, Slack M, Antoni S, Ouattara M, Van Beneden C, Serhan F. The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019. J Infect Dis. 2021 Sep 1;224(Supplement_3):S161-S173. doi: 10.1093/infdis/jiab217. PMID: 34469555; PMCID: PMC8409679.

Mathur P, Khurana S, de Man TJB, Rastogi N, Katoch O, Veeraraghavan B, Neeravi AR, Venkatesan M, Kumar S, Sagar S, Gupta A, Aggarwal R, Soni KD, Malhotra R, Velayudhan A, Siromany V, Malpiedi P, Lutgring J, Laserson K, Gupta N, Srikantiah P, Sharma A. Multiple importations and transmission of colistin-resistant Klebsiella pneumoniae in a hospital in northern India. Infect Control Hosp Epidemiol. 2019 Dec;40(12):1387-1393. doi: 10.1017/ice.2019.252. Epub 2019 Oct 18. PMID: 31625832.

Ninan MM, Venkatesan M, Balaji V, Rupali P, Michael JS. Pulmonary nocardiosis: Risk factors and species distribution from a high burden centre. Indian J Med Microbiol. 2022 Oct-Dec;40(4):582-584. doi: 10.1016/j.ijmmb.2022.08.010. Epub 2022 Sep 8. PMID: 36088197.

Palwe S, Veeraraghavan B, Periasamy H, Khobragade K, Kharat AS. Unorthodox Parenteral β-Lactam and β-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e00168-20. doi: 10.1128/AAC.00168-20. PMID: 32122901; PMCID: PMC7179625.

Opintan JA, Will RC, Kuma GK, Osei M, Akumwena A, Boateng G, Owusu-Okyere G, Antwi L, Opare D, Pragasam AK, Vasudevan K, Srivastava SK, Balaji V, Newman MJ, Dougan G, Mutreja A. Phylogenetic and antimicrobial drug resistance analysis of Vibrio cholerae O1 isolates from Ghana. Microb Genom. 2021 Oct;7(10):000668. doi: 10.1099/mgen.0.000668. PMID: 34714228; PMCID: PMC8627208.

Manesh A, Shankar C, George MM, Jasrotia DS, Lal B, George B, Mathews V, Eapen CE, Joseph P, Subramani K, Rao S, Peter JV, Chacko B, Zachariah A, Sathyendra S, Hansdak SG, Abraham OC, Iyadurai R, Vijayakumar S, Karthik R, Marwick CA, Parcell BJ, Gilbert IH, Veeraraghavan B, Varghese GM. Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South India: A Prospective Cohort Study. Infect Dis Ther. 2023 May;12(5):1319-1335. doi: 10.1007/s40121-023-00803-3. Epub 2023 Apr 16. PMID: 37062023; PMCID: PMC10229510.

Bakthavatchalam YD, Shankar A, Manokaran Y, Walia K, Veeraraghavan B. Can fosfomycin be an alternative therapy for infections caused by E. coli harbouring dual resistance: NDM and four-amino acid insertion in PBP3? JAC Antimicrob Resist. 2023 Mar 4;5(2):dlad016. doi: 10.1093/jacamr/dlad016. PMID: 36880086; PMCID: PMC9985326.

Balaji V, Dinh DM, Kane AV, Soofi S, Ahmed I, Rizvi A, Chatterjee M, Babji S, Duara J, Moy J, Naumova EN, Wanke CA, Ward HD, Bhutta ZA. Longitudinal Analysis of the Intestinal Microbiota among a Cohort of Children in Rural and Urban Areas of Pakistan. Nutrients. 2023 Feb 28;15(5):1213. doi: 10.3390/nu15051213. PMID: 36904212; PMCID: PMC10005232.

Sathya Kumar AM, George MM, Bhanuprasad K, John GM, Korula A, Abraham A, Mathews V, Kulkarni UP, Shankar C, Premkumar PS, Chacko B, Subramani K, Varghese GM, Balaji V, George B. Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy. Ann Clin Microbiol Antimicrob. 2023 Feb 15;22(1):12. doi: 10.1186/s12941-023-00561-7. PMID: 36793051; PMCID: PMC9933361.

Devanga Ragupathi NK, Veeraraghavan B, Karunakaran E, Monk PN. Editorial: Biofilm-mediated nosocomial infections and its association with antimicrobial resistance: Detection, prevention, and management. Front Med (Lausanne). 2022 Aug 1;9:987011. doi: 10.3389/fmed.2022.987011. PMID: 35979211; PMCID: PMC9376627.

Prakash JAJ, Jacob JJ, Rachel T, Vasudevan K, Amladi A, Iyadurai R, Manesh A, Veeraraghavan B. Genomic analysis of Brucella melitensis reveals new insights into phylogeny and evolutionary divergence. Indian J Med Microbiol. 2023 Jul-Aug;44:100360. doi: 10.1016/j.ijmmb.2023.02.003. Epub 2023 May 11. PMID: 37356834.

Jacob JJ, Solaimalai D, Rachel T, Pragasam AK, Sugumar S, Jeslin P, Anandan S, Veeraraghavan B. A secular trend in invasive non-typhoidal Salmonella in South India, 2000-2020: Identification challenges and antibiogram. Indian J Med Microbiol. 2022 Oct-Dec;40(4):536-540. doi: 10.1016/j.ijmmb.2022.07.015. Epub 2022 Aug 17. PMID: 35987666.

Lakshmi Ss J, Prabaa Ms D, Murugan D, Anandan S, Veeraraghavan B. Real-time multiplex PCR assay reveals the increased prevalence of Campylobacter spp and diarrhoeagenic Escherichia coli in humans from Vellore, South India. J Med Microbiol. 2022 Jan;71(1). doi: 10.1099/jmm.0.001478. PMID: 35037615.

Pragasam AK, Shankar C, Anandan S, Verghese VP, Veeraraghavan B. Alarming increase in carbapenemase-producing Klebsiella spp causing bloodstream infections in pediatric population in India. J Infect Dev Ctries. 2017 Sep 30;11(9):736-737. doi: 10.3855/jidc.8038. PMID: 31600166.

Bakthavatchalam YD, Routray A, Mane A, Kamat S, Gupta A, Bari AK, Rohit A, Poojary A, Mukherjee DN, Sethuraman N, Munshi N, Shah S, Balaji V, Gupta Y. In vitro activity of Ceftazidime-Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019. Diagn Microbiol Infect Dis. 2022 May;103(1):115652. doi: 10.1016/j.diagmicrobio.2022.115652. Epub 2022 Jan 31. PMID: 35255290.

Sahai N, Arunachalam DK, Morris T, Copas A, Samuel P, Mohan VR, Abraham V, Selwyn JA, Kumar P, Rose W, Balaji V, Kang G, John J. An observer-blinded, cluster randomised trial of a typhoid conjugate vaccine in an urban South Indian cohort. Trials. 2023 Aug 3;24(1):492. doi: 10.1186/s13063-023-07555-y. PMID: 37537677; PMCID: PMC10399005.

Rosemol Varghese​, Binesh Lal Yesudhason, Leena Robinson Vimala​, Ayyanraj Neeravi​, Kavipriya Anandhan​, Pavithra Baskar​, Divyaa Elangovan​, Abi Manesh​, Prince James, Richa Gupta, Balaji Veeraraghavan. Pneumococcal serotypes causing non-invasive pneumonia in adults from a South Indian tertiary care hospital and the impact of the newer conjugate vaccines ACCESS MICROBIOLOGY Volume 3, Issue 12.https://doi.org/10.1099/acmi.0.000258

Berman D, Chandy SJ, Cansdell O, Moodley K, Veeraraghavan B, Essack SY. Global access to existing and future antimicrobials and diagnostics: antimicrobial subscription and pooled procurement. Lancet Glob Health. 2021 Dec 13:S2214-109X(21)00463-0. doi: 10.1016/S2214-109X(21)00463-0. Epub ahead of print. PMID: 34914900.

Sutcliffe CG, Shet A, Varghese R, Veeraraghavan B, Manoharan A, Wahl B, Chandy S, Sternal J, Khan R, Singh RK, Santosham M, Arora NK. Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study. BMC Infect Dis. 2019 Jul 10;19(1):605. doi: 10.1186/s12879-019-4254-2. PMID: 31291902; PMCID: PMC6621985.

Bakthavatchalam YD, Walia K, Veeraraghavan B. Susceptibility testing for aztreonam plus ceftazidime/avibactam combination: A general guidance for clinical microbiology laboratories in India. Indian J Med Microbiol. 2022 Jan-Mar;40(1):3-6. doi: 10.1016/j.ijmmb.2021.12.006. Epub 2021 Dec 20. PMID: 34949482.

Ms DP, Ss JL, Prakash JAJ, David KS, Alagar V, Veeraraghavan B. An unusual case of infective spondylodiscitis caused by Campylobacter fetus subsp. fetus: molecular characterization by whole-genome sequencing. Access Microbiol. 2021 Jul 8;3(7):000240. doi: 10.1099/acmi.0.000240. PMID: 34595392; PMCID: PMC8479959.

Bakthavatchalam YD, Walia K, Veeraraghavan B. Susceptibility testing for aztreonam plus ceftazidime/avibactam combination: A general guidance for clinical microbiology laboratories in India. Indian J Med Microbiol. 2021 Dec 20:S0255-0857(21)04726-5. doi: 10.1016/j.ijmmb.2021.12.006. Epub ahead of print. PMID: 34949482.

Anandan S, Damodaran S, Gopi R, Bakthavatchalam YD, Veeraraghavan B. Rapid Screening for Carbapenem Resistant Organisms: Current Results and Future Approaches. J Clin Diagn Res. 2015 Sep;9(9):DM01-3. doi: 10.7860/JCDR/2015/14246.6530. Epub 2015 Sep 1. PMID: 26500909; PMCID: PMC4606238.

Lakshmi Ss J, Prabaa Ms D, Murugan D, Anandan S, Veeraraghavan B. Real-time multiplex PCR assay reveals the increased prevalence of Campylobacter spp and diarrhoeagenic Escherichia coli in humans from Vellore, South India. J Med Microbiol. 2022 Jan;71(1). doi: 10.1099/jmm.0.001478. PMID: 35037615.

Shankar C, Jacob JJ, Sugumar SG, Natarajan L, Rodrigues C, Mathur P, Mukherjee DN, Sharma A, Chitnis DS, Bharagava A, Manesh A, Gunasekaran K, Veeraraghavan B. Distinctive Mobile Genetic Elements Observed in the Clonal Expansion of Carbapenem-Resistant Klebsiella pneumoniae in India. Microb Drug Resist. 2021 Aug;27(8):1096-1104. doi: 10.1089/mdr.2020.0316. Epub 2021 Mar 15. PMID: 33720791.

Sharma NC, Anandan S, Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Vasudevan K, Kumar D, Gupta SK, Sangal L, Veeraraghavan B. Genetic Diversity of Clinical Bordetella Pertussis ST2 Strains in comparison with Vaccine Reference Strains of India. J Genomics. 2021 Sep 3;9:38-42. doi: 10.7150/jgen.58823. PMID: 34527084; PMCID: PMC8437686.

Christina Rachel S, Marilyn Mary Ninan, Manigandan Venkatesan, Balaji Veeraraghavan, Molecular characterization of Cryptococcus species using Whole genome based MLST: A pilot study, Indian Journal of Medical Microbiology, Volume 39, Supplement,2021,Page S113, ISSN 0255-0857, https://doi.org/10.1016/j.ijmmb.2021.08.388. (https://www.sciencedirect.com/science/article/pii/S0255085721045679)

Waddington C, Carey ME, Boinett CJ, Higginson E, Veeraraghavan B, Baker S. Exploiting genomics to mitigate the public health impact of antimicrobial resistance. Genome Med. 2022 Feb 16;14(1):15. doi: 10.1186/s13073-022-01020-2. PMID: 35172877; PMCID: PMC8849018.

Yamuna Devi Bakthavatchalam, Karthick Vasudevan, ShomaVinay Rao, Santosh Varughese, Priscilla Rupali, Maki Gina, Marcus Zervos, John Victor Peter, Balaji Veeraraghavan, Genomic portrait of community-associated methicillin-resistant Staphylococcus aureus ST772-SCCmec V lineage from India, Gene Reports, Volume 24, 2021, 101235, ISSN 2452-0144, https://doi.org/10.1016/j.genrep.2021.101235. https://www.sciencedirect.com/science/article/pii/S245201442100220X)

Varghese R, Daniel JL, Neeravi A, Baskar P, Manoharan A, Sundaram B, Manchanda V, Saigal K, Yesudhasan BL, Veeraraghavan B. Multicentric Analysis of Erythromycin Resistance Determinants in Invasive Streptococcus pneumoniae; Associated Serotypes and Sequence Types in India. Curr Microbiol. 2021 Aug;78(8):3239-3245. doi: 10.1007/s00284-021-02594-7. Epub 2021 Jul 5. PMID: 34223923.

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Murugan D, Ranjan R, Gautam V, Gupta P, Johnson J, Sharma NC, Mutreja A, Haldar P, Kumar A, Bhatnagar P, Sangal L, Veeraraghavan B. Divergent evolution of Corynebacterium diphtheriae in India: An update from National Diphtheria Surveillance network. PLoS One. 2021 Dec 15;16(12):e0261435. doi: 10.1371/journal.pone.0261435. PMID: 34910778; PMCID: PMC8673651.

Veeraraghavan B, Varghese R, Saigal K, Balasubramanian S, Bai PSP, Lal Y B, Neeravi A, Baskar P, Anandhan K, Kumar CPG, Jayaraman Y, Nag VL, Baveja S, J B, Joshi SA, Iyer R. Activity of novel lactone ketolide nafithromycin against multicentric invasive and non-invasive pneumococcal isolates collected in India. JAC Antimicrob Resist. 2021 Jun 1;3(2):dlab066. doi: 10.1093/jacamr/dlab066. PMID: 34223128; PMCID: PMC8210042.

Veeraraghavan B, Pragasam AK, Ray P, Kapil A, Nagaraj S, Perumal SPB, Saigal K, Thomas M, Gupta M, Rongsen-Chandola T, Jinka DR, Shastri J, Alexander AP, Koshy RM, De A, Singh A, Evelyn Ebenezer S, Dutta S, Bavdekar A, More D, Sanghavi S, Nayakanti RR, Jacob JJ, Amladi A, Anandan S, Abirami BS, Bakthavatchalam YD, Sethuvel DPM, John J, Kang G. Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management. J Infect Dis. 2021 Nov 23;224(Supple 5):S502-S516. doi: 10.1093/infdis/jiab144. PMID: 35238369; PMCID: PMC8892543.

Karthikeyan AS, Srinivasan M, Kanungo S, Sinha B, Shrivastava A, Ramanujam K, Ganesan SK, Subramaniam S, Sindhu KN, Krishna S, Samuel P, Rose W, Mohan VR, Veeraraghavan B, Rongsen-Chandola T, Dutta S, Bavdekar A, John J, Kang G. Antibiotics for Fever Among Children: Findings From the Surveillance for Enteric Fever in India Cohorts. J Infect Dis. 2021 Nov 23;224(Supple 5):S494-S501. doi: 10.1093/infdis/jiab115. PMID: 35238360; PMCID: PMC8892537.

Muthuirulandi Sethuvel DP, Anandan S, Murugan D, Asokan K, Vasudevan K, Jacob JJ, Walia K, Michael JS, Veeraraghavan B. Hybrid genome assembly of Shigella sonnei reveals the novel finding of chromosomal integration of an IncFII plasmid carrying a mphA gene. Access Microbiol. 2020 Dec 9;3(2):000189. doi: 10.1099/acmi.0.000189. PMID: 34151144; PMCID: PMC8209639.

Naha A, Vijayakumar S, Lal B, Shankar BA, Chandran S, Ramaiah S, Veeraraghavan B, Anbarasu A. Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of sulbactam-durlobactam holds promise for therapeutic intervention. J Cell Biochem. 2021 Dec;122(12):1946-1957. doi: 10.1002/jcb.30156. Epub 2021 Oct 1. PMID: 34597421.

Palwe S, Veeraraghavan B, Periasamy H, Khobragade K, Kharat AS. Unorthodox Parenteral β-Lactam and β-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e00168-20. doi: 10.1128/AAC.00168-20. PMID: 32122901; PMCID: PMC7179625.

Shankar C, Mathur P, Venkatesan M, Pragasam AK, Anandan S, Khurana S, Veeraraghavan B. Rapidly disseminating blaOXA-232 carrying Klebsiella pneumoniae belonging to ST231 in India: multiple and varied mobile genetic elements. BMC Microbiol. 2019 Jun 24;19(1):137. doi: 10.1186/s12866-019-1513-8. PMID: 31234800; PMCID: PMC6591861

Shankar C, Muthuirulandi Sethuvel DP, Neeravi AR, Venkatesan M, Devanga Ragupathi NK, Anandan S, Veeraraghavan B. Identification of plasmids by PCR based replicon typing in bacteremic Klebsiella pneumoniae. Microb Pathog. 2020 Nov;148:104429. doi: 10.1016/j.micpath.2020.104429. Epub 2020 Aug 8. PMID: 32781101.

Karunanayake L, Balaji V, Gunawardana KDN, Varghese R, Ariram V, Dassanayake M, et al. Antimicrobial susceptibility and serotypes of Neisseria meningitidis a nd Streptococcus pneumoniae in Sri Lanka: Experience from the National Reference Laboratory. Asian Pacific Journal of Tropical Medicine. [Article]. 2022;15(3):114-20. Link

Gladstone RA, Siira L, Brynildsrud OB, Vestrheim DF, Turner P, Clarke SC, Srifuengfung S, Ford R, Lehmann D, Egorova E, Voropaeva E, Haraldsson G, Kristinsson KG, McGee L, Breiman RF, Bentley SD, Sheppard CL, Fry NK, Corander J, Toropainen M, Steens A; Global Pneumococcal Sequencing Consortium. International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease. Vaccine. 2022 Feb 11;40(7):1054-1060. doi: 10.1016/j.vaccine.2021.10.046. Epub 2022 Jan 5. PMID: 34996643; PMCID: PMC8820377.

Ramamurthy, Thandavarayana;Pragasam, Agila Kumarib;Taylor-Brown, Alycec;Will, Robert C.d;Vasudevan, Karthickb, e;Das, Bhabatoshf;Srivastava, Sunil Kumarg;Chowdhury, Goutama;Mukhopadhyay, Asish K.a;Dutta, Shantaa;Veeraraghavan, Balajib;Thomson, Nicholas R.C Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic Nature Communications Volume 13, Issue 1 December 2022 Article number 3864 10.1038/s41467-022-31391-4

Lo SW, Mellor K, Cohen R, Alonso AR, Belman S, Kumar N, Hawkins PA, Gladstone RA, von Gottberg A, Veeraraghavan B, Ravikumar KL, Kandasamy R, Pollard SAJ, Saha SK, Bigogo G, Antonio M, Kwambana-Adams B, Mirza S, Shakoor S, Nisar I, Cornick JE, Lehmann D, Ford RL, Sigauque B, Turner P, Moïsi J, Obaro SK, Dagan R, Diawara I, Skoczyńska A, Wang H, Carter PE, Klugman KP, Rodgers G, Breiman RF, McGee L, Bentley SD, Almagro CM, Varon E; Global Pneumococcal Sequencing Consortium. Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study. Lancet Microbe. 2022 Aug 16:S2666-5247(22)00158-6. doi: 10.1016/S2666-5247(22)00158-6. Epub ahead of print. PMID: 35985351.

Will RC, Ramamurthy T, Sharma NC, Veeraraghavan B, Sangal L, Haldar P, Pragasam AK, Vasudevan K, Kumar D, Das B, Heinz E, Melnikov V, Baker S, Sangal V, Dougan G, Mutreja A. Spatiotemporal persistence of multiple, diverse clades and toxins of Corynebacterium diphtheriae. Nat Commun. 2021 Mar 8;12(1):1500. doi: 10.1038/s41467-021-21870-5. PMID: 33686077; PMCID: PMC7940655.

Senchenkova SN, Shashkov AS, Shneider MM, Popova AV, Balaji V, Biswas I, Knirel YA, Kenyon JJ. A novel ItrA4 d-galactosyl 1-phosphate transferase is predicted to initiate synthesis of an amino sugar-lacking K92 capsular polysaccharide of Acinetobacter baumannii B8300. Res Microbiol. 2021 Apr-May;172(3):103815. doi: 10.1016/j.resmic.2021.103815. Epub 2021 Mar 3. PMID: 33667610.

Hamide A, Mahapatra R, Noronha AK, Kandan B, Shankar C, Veeraraghavan B. Hypervirulent Klebsiella pneumoniae infection presenting as endocarditis and liver abscess. Trop Doct. 2022 Oct;52(4):583-585. doi: 10.1177/00494755221101777. Epub 2022 Jul 26. PMID: 35892169.

Aye AMM, Bai X, Borrow R, Bory S, Carlos J, Caugant DA, Chiou CS, Dai VTT, Dinleyici EC, Ghimire P, Handryastuti S, Heo JY, Jennison A, Kamiya H, Tonnii Sia L, Lucidarme J, Marshall H, Putri ND, Saha S, Shao Z, Sim JHC, Smith V, Taha MK, Van Thanh P, Thisyakorn U, Tshering K, Vázquez J, Veeraraghavan B, Yezli S, Zhu B. Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative. J Infect. 2020 Nov;81(5):698-711. doi: 10.1016/j.jinf.2020.07.025. Epub 2020 Jul 27. PMID: 32730999.

Irulappan M, Mutreja A, Veeraraghavan B. Genomic surveillance for comprehensive Shigella management. Lancet Infect Dis. 2023 Jan 30:S1473-3099(23)00006-3. doi: 10.1016/S1473-3099(23)00006-3. Epub ahead of print. PMID: 36731479.

Mathew SK, Rao SV, Prabha R, Neely MN, Mathew BS, Aruldhas BW, Veeraraghavan B, Kandasamy S. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients. J Clin Pharmacol. 2023 Jan;63(1):57-65. Link

Chandran S, Manokaran Y, Vijayakumar S, Shankar BA, Bakthavatchalam YD, Dwarakanathan HT, Yesudason BL, Veeraraghavan B. Enhanced bacterial killing with a combination of sulbactam/minocycline against dual carbapenemase-producing Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 2023 May;42(5):645-651. doi: 10.1007/s10096-023-04583-z. Epub 2023 Mar 11. PMID: 36905566.

Vijayakumar S, Anandan S, Ms DP, Kanthan K, Vijayabaskar S, Kapil A, Ray P, Sistla S, Bhattacharya S, Wattal C, Thirunarayan, Deotale V, Mathur P, Walia K, Ohri VC, Veeraraghavan B. Insertion sequences and sequence types profile of clinical isolates of carbapenem-resistant A. baumannii collected across India over four year period. J Infect Public Health. 2020 Jul;13(7):1022-1028. doi: 10.1016/j.jiph.2019.11.018. Epub 2019 Dec 23. PMID: 31874816

Priya T T, Jacob JJ, M Y, Karthik R, Iyadurai R, G K, Devi B Y, Walia K, Veeraraghavan B. Is it time to move on to gene-based Salmonella typing: Evidence and implications. Indian J Med Microbiol. 2023 Jul-Aug;44:100359. doi: 10.1016/j.ijmmb.2023.02.002. Epub 2023 May 11. PMID: 37356840.

Ragupathi NKD, Muthuirulandi Sethuvel DP, Gopikrishnan M, Dwarakanathan HT, Murugan D, Biswas I, Bakthavachalam YD, Murugesan M, George Priya Doss C, Monk PN, Karunakaran E, Veeraraghavan B. Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogens. Microb Pathog. 2023 May;178:106064. doi: 10.1016/j.micpath.2023.106064. Epub 2023 Mar 9. PMID: 36898591.

Soman R, Veeraraghavan B, Hegde A, Jiandani P, Mehta Y, Nagavekar V, Rodrigues C, Singh RK, Swaminathan S, Todi S, Varma S, Patil S, Barkate H. Indian consensus on the management of CRE infection in critically ill patients (ICONIC) - India. Expert Rev Anti Infect Ther. 2019 Aug;17(8):647-660. doi: 10.1080/14787210.2019.1647103. Epub 2019 Aug 2. PMID: 31375039.

Walia K, Mendelson M, Kang G, Venkatasubramanian R, Sinha R, Vijay S, Veeraraghavan B, Basnyat B, Rodrigues C, Bansal N, Ray P, Mathur P, Gopalakrishnan R, Ohri VC. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship? Lancet Infect Dis. 2023 Aug;23(8):e301-e309. doi: 10.1016/S1473-3099(23)00124-X. Epub 2023 Jun 5. PMID: 37290476.

Solaimalai D, Devanga Ragupathi NK, Ranjini K, Paul H, Verghese VP, Michael JS, Veeraraghavan B, James EJ. Ultrasound gel as a source of hospital outbreaks: Indian experience and literature review. Indian J Med Microbiol. 2019 Apr-Jun;37(2):263-267. doi: 10.4103/ijmm.IJMM_19_249. PMID: 31745029

Wyres KL, Nguyen TNT, Lam MMC, Judd LM, van Vinh Chau N, Dance DAB, Ip M, Karkey A, Ling CL, Miliya T, Newton PN, Lan NPH, Sengduangphachanh A, Turner P, Veeraraghavan B, Vinh PV, Vongsouvath M, Thomson NR, Baker S, Holt KE. Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Med. 2020 Jan 16;12(1):11. doi: 10.1186/s13073-019-0706-y. PMID: 31948471; PMCID: PMC6966826.

Bakthavatchalam YD, Shankar A, Muniyasamy R, Peter JV, Marcus Z, Triplicane Dwarakanathan H, Gunasekaran K, Iyadurai R, Veeraraghavan B. Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital. J Antimicrob Chemother. 2020 Aug 1;75(8):2156-2159. doi: 10.1093/jac/dkaa142. PMID: 32361727.

Venkat A, Falconi TMA, Cruz M, Hartwick MA, Anandan S, Kumar N, Ward H, Veeraraghavan B, Naumova EN. Spatiotemporal Patterns of Cholera Hospitalization in Vellore,India. Int J Environ Res Public Health. 2019 Nov 2;16(21):4257. doi: 10.3390/ijerph16214257. PMID: 31684018; PMCID: PMC6862112.

S LJ, Basker MM, Verghese VP, Anandan S, Sethuvel DPM, Abirami SB, Mani T, Balaji V, Prakash JAJ. A Seroepidemiological Survey for Pertussis among Adolescents. Indian J Pediatr. 2021 May;88(5):509. doi: 10.1007/s12098-021-03696-7. Epub 2021 Feb 17. PMID: 33594619.

Vijay S, Sharma M, Misri J, Shome BR, Veeraraghavan B, Ray P, Ohri VC, Walia K. An integrated surveillance network for antimicrobial resistance, India. Bull World Health Organ. 2021 Aug 1;99(8):562-571. doi: 10.2471/BLT.20.284406. Epub 2021 Jun 1. Erratum in: Bull World Health Organ. 2022 Apr 1;100(4):292. PMID: 34354311; PMCID: PMC8319865.

Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, Anandan S, Swaminathan S, Sundaram B. Colistin-sparing approaches with newer antimicrobials to treat carbapenem-resistant organisms: Current evidence and future prospects. Indian J Med Microbiol. 2019 Jan-Mar;37(1):72-90. doi: 10.4103/ijmm.IJMM_19_215. PMID: 31424014.

Amladi A, Lal Y B, Jacob JJ, Anandan S, Veeraraghavan B. Draft genome sequence of carbapenem-resistant Elizabethkingia anophelis strain BP8467 clinical isolate from India. J Glob Antimicrob Resist. 2020 Jun;21:200-202. doi: 10.1016/j.jgar.2020.04.003. Epub 2020 Apr 21. PMID: 32330579.

Elangovan D, Neeravi A, Sahni RD, Santhanam S, Beck MM, Adhiya R, Kwatra G, Solaimalai D, Veeraraghavan B. Serotype distribution and antimicrobial susceptibility profile of invasive group B streptococcal disease-in South Indian population. Indian J Med Microbiol. 2023 Sep-Oct;45:100392. doi: 10.1016/j.ijmmb.2023.100392. Epub 2023 Jun 7. PMID: 37573061.

Bakthavatchalam YD, Vasudevan K, Amladi A, Anandan S, Peter JV, Veeraraghavan B. Hybrid assembly of multi-drug resistant, highly virulent methicillin resistant Staphylococcus aureus ST772-SCCmec V lineage: Maximising its potential for dissemination similar to USA300 clone. Genomics. 2020 Nov;112(6):5248-5253. doi: 10.1016/j.ygeno.2020.09.051. Epub 2020 Sep 23. PMID: 32976975.

Simoes EA, Balraj V, Selvakumar R, John TJ. Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine. Am J Dis Child. 1988 Mar;142(3):309-11. doi: 10.1001/archpedi.1988.02150030083026. PMID: 3257842.

Uzzell CB, Abraham D, Rigby J, Troman CM, Nair S, Elviss N, Kathiresan L, Srinivasan R, Balaji V, Zhou NA, Meschke JS, John J, Kang G, Feasey N, Mohan VR, Grassly NC. Environmental surveillance for Salmonella Typhi and its association with typhoid fever incidence in India and Malawi. J Infect Dis. 2023 Sep 29:jiad427. doi: 10.1093/infdis/jiad427. Epub ahead of print. PMID: 37775091.

Pragasam AK, Balaji V, Mutreja A. Understanding antimicrobial resistance to manage cholera. Nat Microbiol. 2023 Oct;8(10):1754-1755. doi: 10.1038/s41564-023-01482-z. PMID: 37770746.

Shankar C, Nabarro LE, Anandan S, Ravi R, Babu P, Munusamy E, Jeyaseelan V, Rupali P, Verghese VP, Veeraraghavan B. Extremely High Mortality Rates in Patients with Carbapenem-resistant, Hypermucoviscous Klebsiella pneumoniae Blood Stream Infections. J Assoc Physicians India. 2018 Dec;66(12):13-16. PMID: 31313543.

Ss JL, Muthuirulandi Sethuvel DP, Baskaran A, Veeraraghavan B. Complete Genome Analysis of Campylobacter jejuni subsp. jejuni Isolated from Bloodstream Infection. Microbiol Resour Announc. 2021 Mar 18;10(11):e00065-21. doi: 10.1128/MRA.00065-21. PMID: 33737354; PMCID: PMC7975872.

Bakthavatchalam YD, Rao SV, Isaac B, Manesh A, Nambi S, Swaminathan S, Nagvekar V, Nangia V, John PV, Veeraraghavan B. A comparative assessment of clinical, pharmacological and antimicrobial profile of novel anti-methicillin-resistant Staphylococcus aureus agent levonadifloxacin: Therapeutic role in nosocomial and community infections. Indian J Med Microbiol. 2019 Oct-Dec;37(4):478-487. doi: 10.4103/ijmm.IJMM_20_34. PMID: 32436868.

Bakthavatchalam YD, Ramaswamy B, Janakiraman R, Steve RJ, Veeraraghavan B. Genomic insights of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) with reduced teicoplanin susceptibility: A case of fatal necrotizing fasciitis. J Glob Antimicrob Resist. 2018 Sep;14:242-245. doi: 10.1016/j.jgar.2018.05.006. Epub 2018 May 15. PMID: 29775787.

Jha L, Y BL, Ragupathi NKD, Veeraraghavan B, Prakash JAJ. Phenotypic and Genotypic Correlation of Antimicrobial Susceptibility of Bacteroides fragilis: Lessons Learnt. Cureus. 2023 Mar 16;15(3):e36268. doi: 10.7759/cureus.36268. PMID: 37073211; PMCID: PMC10105825.

Jacob JJ, Rachel T, Shankar BA, Gunasekaran K, Iyadurai R, Anandan S, Veeraraghavan B. MLST based serotype prediction for the accurate identification of non typhoidal Salmonella serovars. Mol Biol Rep. 2020 Oct;47(10):7797-7803. doi: 10.1007/s11033-020-05856-y. Epub 2020 Oct 1. PMID: 33001311.

Dhar N, Mohamed E, Kirstein F, Williams M, Dorasamy S, van Zyl P, Robertson MJ, Anderson T, Harden LM, Jardine K, Veeraraghavan B, Wilson S, Tippoo P, Madhi SA, Kwatra G. Immune responses against group B Streptococcus monovalent and pentavalent capsular polysaccharide tetanus toxoid conjugate vaccines in Balb/c mice. iScience. 2023 Jul 13;26(8):107380 doi: 10.1016/j.isci.2023.107380. PMID: 37575182; PMCID: PMC10415928.

Rafiqullah IM, Varghese R, Hellmann KT, Velmurugan A, Neeravi A, Kumar Daniel JL, Vidal JE, Kompithra RZ, Verghese VP, Veeraraghavan B, Robinson DA. Pneumococcal population genomics changes during the early time period of conjugate vaccine uptake in southern India. Microb Genom. 2024 Feb;10(2). doi: 10.1099/mgen.0.001191. PMID: 38315173.

Hujer AM, Marshall SH, Mack AR, Hujer KM, Bakthavatchalam YD, Umarkar K, Palwe SR, Takalkar S, Joshi PR, Shrivastava R, Periasamy H, Bhagwat SS, Patel MV, Veeraraghavan B, Bonomo RA. Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam. mBio. 2023 Oct 27;14(6):e0111823. doi: 10.1128/mbio.01118-23. Epub ahead of print. PMID: 37889005; PMCID: PMC10746216.

Vijayakumar S, Swetha RG, Bakthavatchalam YD, Vasudevan K, Abirami Shankar B, Kirubananthan A, Walia K, Ramaiah S, Biswas I, Veeraraghavan B, Anbarasu A. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. Microbiol Spectr. 2024 Feb 6;12(2):e0251123. doi: 10.1128/spectrum.02511-23. Epub 2024 Jan 12. PMID: 38214512; PMCID: PMC10846133.

Singh KA, Anandan S, Sharma A, Kumar SE, Solaimalai D, Veeraraghavan B, Goel A, Eapen CE, Zachariah UG. High Mortality With Non-O1/Non-O139 Vibrio cholera Bacteraemia in Patients With Cirrhosis. J Clin Exp Hepatol. 2024 May-Jun;14(3):101346. doi: 10.1016/j.jceh.2024.101346. Epub 2024 Jan 17. PMID: 38371607; PMCID: PMC10869911.

Saseedharan S, Dubey D, Singh RK, Zirpe K, Choudhuri AH, Mukherjee DN, Gupta N, Sahasrabudhe S, Soni S, Kulkarni S, Walse P, Vora AC, Thomas J, Tayade A, Bhadarke G, Kishore K, Paliwal Y, Patil P, Reddy PK, Nagvekar V, Veeraraghavan B. Treatment challenges in the management of difficult-to-treat gram-positive infections: A consensus view apropos therapeutic role of novel anti-MRSA antibiotics, levonadifloxacin (IV) and alalevonadifloxacin (oral). Indian J Med Microbiol. 2024 Jan 21;47:100528. doi: 10.1016/j.ijmmb.2024.100528. Epub ahead of print. PMID: 38228227.

Ghafur A, Balaguru P, Ramanan SG, Rajendranath R, Raj R, Zehran M, Raja T, Easow JM, Srinivasan S, Devaprasad D, Sukumar T, Nilgar P, Sakthivel K, Nirumal RM, Chandra K, Lakshmi SV, Sethuraman N, Devi Bakthavatchalam Y, Veeraraghavan B. Diving deep for the needle in the haystack: An outbreak investigation of Burkholderia cenocepacia bacteremia. Infect Control Hosp Epidemiol. 2024 Jan 4:1-4. doi: 10.1017/ice.2023.241. Epub ahead of print. PMID: 38173359.

Ahamed SKT, Rai S, Guin C, Jameela RM, Dam S, Muthuirulandi Sethuvel DP, Balaji V, Giri N. Characterizations of novel broad-spectrum lytic bacteriophages Sfin-2 and Sfin-6 infecting MDR Shigella spp. with their application on raw chicken to reduce the Shigella load. Front Microbiol. 2023 Nov 29;14:1240570. doi: 10.3389/fmicb.2023.1240570. PMID: 38094623; PMCID: PMC10716491.

Basu S, Veeraraghavan B, Anbarasu A. Impact of PmrB mutations on clinical Klebsiella pneumoniae with variable colistin-susceptibilities: Structural insights and potent therapeutic solutions. Chem Biol Drug Des. 2024 Jan;103(1):e14381. doi: 10.1111/cbdd.14381. Epub 2023 Oct 24. PMID: 37875387.

Soman R, Sirsat R, Sunavala A, Punatar N, Mehta J, Rodrigues C, Veeraraghavan B. Successful treatment of sino-pulmonary infection & skull base osteomyelitis caused by New Delhi metallo-β-lactamase-producing Pseudomonas aeruginosa in a renal transplant recipient by using an investigational antibiotic cefepime/zidebactam (WCK 5222). Eur J Clin Microbiol Infect Dis. 2024 Feb 28. doi: 10.1007/s10096-024-04791-1. Epub ahead of print. PMID: 38416290.

Kharat AS, Makwana N, Nasser M, Gayen S, Yadav B, Kumar D, Veeraraghavan B, Mercier C. Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010-2020 decade in India. Int J Antimicrob Agents. 2024 Feb 29:107125. doi: 10.1016/j.ijantimicag.2024.107125. Epub ahead of print. PMID: 38431109.

Singhal, Tanu et al. “Burkholderia cepacia complex as a cause of community acquired bacteremia in a young immuncompetent male.” Indian journal of medical microbiology vol. 46 (2023): 100422. doi:10.1016/j.ijmmb.2023.100422

Veeraraghavan, Balaji et al. “Loss of exclusivity of ceftazidime/avibactam in low- and middle-income countries: a test for antibiotic stewardship practice.” The Lancet regional health. Southeast Asia vol. 15 100225. 27 May. 2023, doi:10.1016/j.lansea.2023.100225

Veeraraghavan B, Bakthavatchalam YD, Sahni RD. Lessons learned from an external quality assurance program in applying CLSI interpretive criteria for reporting piperacillin/tazobactam susceptibility. Indian J Med Microbiol. 2024 Mar 3:100552. doi: 10.1016/j.ijmmb.2024.100552. Epub ahead of print. PMID: 38442789.

Dubey D, Roy M, Shah TH, Bano N, Kulshrestha V, Mitra S, Sangwan P, Dubey M, Imran A, Jain B, Velmurugan A, Bakthavatchalam YD, Veeraraghavan B. Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis patient: a case report. Ann Clin Microbiol Antimicrob. 2023 Jul 5;22(1):55. doi: 10.1186/s12941-023-00606-x. PMID: 37408075; PMCID: PMC10324185.

Sharma M, Jain M, Veeraraghavan B, Rodrigues C, Bansal N, Nambi PS, Nangia S, Singhal T, Walia K. Target product profiles for diagnosis of sepsis: Proposing a new approach for diagnostic innovation. Indian J Med Res. 2023 May;157(5):395-402. doi: 10.4103/ijmr.ijmr_1936_22. PMID: 37322632; PMCID: PMC10443725.

John J, Bavdekar A, Rongsen-Chandola T, Dutta S, Gupta M, Kanungo S, Sinha B, Srinivasan M, Shrivastava A, Bansal A, Singh A, Koshy RM, Jinka DR, Thomas MS, Alexander AP, Thankaraj S, Ebenezer SE, Karthikeyan AS, Kumar D, Njarekkattuvalappil SK, Raju R, Sahai N, Veeraraghavan B, Murhekar MV, Mohan VR, Natarajan SK, Ramanujam K, Samuel P, Lo NC, Andrews J, Grassly NC, Kang G; NSSEFI Study Team. Burden of Typhoid and Paratyphoid Fever in India. N Engl J Med. 2023 Apr 20;388(16):1491-1500. doi: 10.1056/NEJMoa2209449. PMID: 37075141; PMCID: PMC10116367.

Carey ME, Dyson ZA, Ingle DJ, Amir A, Aworh MK, Chattaway MA, Chew KL, Crump JA, Feasey NA, Howden BP, Keddy KH, Maes M, Parry CM, Van Puyvelde S, Webb HE, Afolayan AO, Alexander AP, Anandan S, Andrews JR, Ashton PM, Basnyat B, Bavdekar A, Bogoch II, Clemens JD, da Silva KE, De A, de Ligt J, Diaz Guevara PL, Dolecek C, Dutta S, Ehlers MM, Francois Watkins L, Garrett DO, Godbole G, Gordon MA, Greenhill AR, Griffin C, Gupta M, Hendriksen RS, Heyderman RS, Hooda Y, Hormazabal JC, Ikhimiukor OO, Iqbal J, Jacob JJ, Jenkins C, Jinka DR, John J, Kang G, Kanteh A, Kapil A, Karkey A, Kariuki S, Kingsley RA, Koshy RM, Lauer AC, Levine MM, Lingegowda RK, Luby SP, Mackenzie GA, Mashe T, Msefula C, Mutreja A, Nagaraj G, Nagaraj S, Nair S, Naseri TK, Nimarota-Brown S, Njamkepo E, Okeke IN, Perumal SPB, Pollard AJ, Pragasam AK, Qadri F, Qamar FN, Rahman SIA, Rambocus SD, Rasko DA, Ray P, Robins-Browne R, Rongsen-Chandola T, Rutanga JP, Saha SK, Saha S, Saigal K, Sajib MSI, Seidman JC, Shakya J, Shamanna V, Shastri J, Shrestha R, Sia S, Sikorski MJ, Singh A, Smith AM, Tagg KA, Tamrakar D, Tanmoy AM, Thomas M, Thomas MS, Thomsen R, Thomson NR, Tupua S, Vaidya K, Valcanis M, Veeraraghavan B, Weill FX, Wright J, Dougan G, Argimón S, Keane JA, Aanensen DM, Baker S, Holt KE; Global Typhoid Genomics Consortium Group Authorship. Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes. Elife. 2023 Sep 12;12:e85867. doi: 10.7554/eLife.85867. PMID: 37697804; PMCID: PMC10506625.

Kwatra G, Izu A, Cutland C, Akaba G, Ali MM, Ahmed Z, Beck MM, Barsosio HC, Berkley JA, Chaka TE, Cossa Al, Chakraborty S, Dhar N, Dorji P, Islam M, Keita AM, Mwakio S, Mwarumba S, Medugu N, Mucavele H, Mabombo V, Obaro S, Sigauque B, Sow SO, Saha SK, Santhanam S, Sharma R, Simoes EAF, Sahni RD, Tapia MD, Veeraraghavan B, Madhi SA. Prevalence of group B Streptococcus colonisation in mother–newborn dyads in low-income and middle-income south Asian and African countries: a prospective, observational study. The Lancet Microbe:100897. Link

Ninan MM, Sahni RD, Chacko B, Balaji V, Michael JS. Candida auris: Clinical profile, diagnostic challenge and susceptibility pattern: Experience from a tertiary-care centre in South India. J Glob Antimicrob Resist. 2020 Jun;21:181-185. doi: 10.1016/j.jgar.2019.10.018. Epub 2019 Oct 23. PMID: 31655136.

Sharma A, Azam M, Verma PK, Talwar V, Roy S, Veeraraghavan B, Singh R, Gaind R. Application of LAMP assay for detection of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in ICU admitted sepsis patients: A rapid and cost-effective diagnostic tool. Diagn Microbiol Infect Dis. 2024 Sep;110(1):116398. doi: 10.1016/j.diagmicrobio.2024.116398. Epub 2024 Jun 12. PMID: 38908041.

Soman R, Veeraraghavan B, Hegde A, Varma S, Todi S, Singh RK, Nagavekar V, Rodrigues C, Swaminathan S, Ramsubramanian V, Ansari A, Chaudhry D, Pednekar A, Bhagat S, Patil S, Barkate H. Indian consensus on the managemeNt of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II). Expert Rev Anti Infect Ther. 2024 Jun;22(6):453-468. doi: 10.1080/14787210.2024.2360116. Epub 2024 May 27. Erratum in: Expert Rev Anti Infect Ther. 2024 Jul;22(7):607. doi: 10.1080/14787210.2024.2370086. PMID: 38790080.

Narasimhan V, Pulakkat Warrier S, John JJ, T MP, Varadaraj N, Thomas GG, Veeraraghavan B. Predicting clinical outcomes in Helicobacter pylori-positive patients using supervised learning through the integration of demographic and genomic features. BMC Gastroenterol. 2026 Jan 29;26(1):143. doi: 10.1186/s12876-025-04595-3. PMID: 41606475; PMCID: PMC12922380. Link

Peketi ASK, Svl SKK, P KK, Rangineni J, Veeraraghavan B, Bulagonda EP. Leveraging zeta potential as a surface charge metric for trapping and killing of airborne bacteria. Sci Rep. 2026 Feb 10;16(1):8115. doi: 10.1038/s41598-026-38958-x. PMID: 41663565; PMCID: PMC12960660. Link

Gupta N, Agashe V, Soman R, Vidyarthi K, Gupta R, Sen I, Koley M, Veeraraghavan B, Gupta K. Novel approach in treatment of Burkholderia pseudomallei osteomyelitis: salvage therapy with levonadifloxacin. JAC Antimicrob Resist. 2025 Jul 9;7(4):dlaf122. doi: 10.1093/jacamr/dlaf122. PMID: 40636397; PMCID: PMC12238538.

Halder G, Chaudhuri BN, Veeraraghavan B, Denny P, Dutta P, Chakraborty M, Khan UR, Ganguly SS, Mandal S, Upadhyaya YP, Biswas B, Chakraborty A, Maiti S, Mondal H, Pal S, Dutta S. Antimicrobial resistance and phylogenetic lineages of KPC-2-producing blood-borne Klebsiella pneumoniae subsp. pneumoniae from Kolkata, India during 2015-2024: Emergence of Klebsiella pneumoniae subsp. pneumoniae with blaKPC-2, blaNDM, and blaOXA-48-like triple carbapenemases. Microbiol Spectr. 2025 Aug 5;13(8):e0012625. doi: 10.1128/spectrum.00126-25. Epub 2025 Jun 12. PMID: 40503825; PMCID: PMC12323354.

Gopikrishnan M, Ramireddy S, Bakathavatchalam YD, Varghese RP, Kumar DT, Lal B, Manesh A, Walia K, Veeraraghavan B, Priya Doss CG. Evaluating Antibacterial Efficacy of Cefiderocol and Cefepime/Taniborbactam Against OXA-48-Like and NDM-Expressing Enterobacterales: An In-Vitro and In-Silico Approach. Curr Microbiol. 2025 Oct 25;82(12):578. doi: 10.1007/s00284-025-04543-0. PMID: 41137955.

Irulappan M, Veeraraghavan B. Limitations of repurposing ceftazidime for Stenotrophomonas maltophilia: a cautionary perspective. mSphere. 2025 Aug 26;10(8):e0038425. doi: 10.1128/msphere.00384-25. Epub 2025 Aug 4. PMID: 40757825; PMCID: PMC12379587.

Irulappan M, Jacob JJ, Madhumathi J, Lydia Jennifer S, Kumaresan V, Kumar R, Veeraraghavan B, Sangal L, Nithiyanandam S, Mutreja A. Pertussis in India: Vaccine-driven evolution, waning immunity, and the urgent need for Tdap boosters. Indian J Med Microbiol. 2025 May-Jun;55:100846. doi: 10.1016/j.ijmmb.2025.100846. Epub 2025 Apr 10. PMID: 40221094.

Irulappan M, Murugan D, Ramesh V, Rajendran S, Madhale OP, Kompithra RZ, Jacob JJ, Veeraraghavan B. Draft genome sequence of Bordetella pertussis PS21, a circulating clinical isolate from India. Microbiol Resour Announc. 2025 Nov 13;14(11):e0080125. doi: 10.1128/mra.00801-25. Epub 2025 Sep 30. PMID: 41025834; PMCID: PMC12613897.

Karthik M, Panchal NK, T M, Bakthavatchalam YD, Neeravi A, Abirami B, Walia K, Veeraraghavan B. Evolutionary insights into NDM variants: Identification and functional analysis of novel NDM-58 in Pseudomonas aeruginosa. Microb Pathog. 2025 Jul;204:107574. doi: 10.1016/j.micpath.2025.107574. Epub 2025 Apr 12. PMID: 40228751.

Joel B, Moses V, Veeraraghavan B, Santhanam S, Beck MM, Dhar N, Kwatra G, Sahni RD. Group B Streptococcus vaccine update: A crucial public health initiative for India. Indian J Med Microbiol. 2025 Sep-Oct;57:100917. doi: 10.1016/j.ijmmb.2025.100917. Epub 2025 Jul 11. PMID: 40653108.